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ABSTRACT
Nature is an incredible source of inspiration for the discovery and subsequent devel-
opment of new bioactive compounds. Unfortunately, the synthesis of these molecules is
often prohibitively complex, requiring the installation of multiple functional groups with
intricate three-dimensional architectures critical to their biological activity. Biocatalytic
reactions embody many features of ideal chemical transformations, including the poten-
tial for impeccable selectivity, high catalytic eciency, mild reaction conditions, and the
use of environmentally benign reagents. These advantages have created a demand for new
biocatalysts that expand the portfolio of complexity-generating reactions available to syn-
thetic chemists. Oxidative dearomatization is a powerful transformation in the synthesis
of complex molecules, as it generates a stereocenter and simultaneously producing a com-
pound primed for further reactions. Nature has developed a class of biocatalysts, avin-
dependent monooxygenases, which perform this reaction with an excellent site- and stere-
oselectivity under mild conditions. Our studies on the TropB-catalyzed hydroxylation of
phenolic compounds has dened the substrate scope of these biocatalysts; however, the
mechanistic underpinnings were a mystery. Through analysis of class A FAD monooxyge-
nases and biochemical characterization of TropB we determined that the phenolate form
of the substrate interacts with Tyr239 and Arg206 to control the site- and stereo-selectivity
of the hydroxylation. We then we explore how this control for site- and stereo-selective
is translated to a selection of FAD-dependent monooxygenases. Through a sequence-
proling approach we identied the FDMO AfoD with complementary selectivity com-
pared to TropB. We determined by probing similarly positioned residues through muta-
xv
genesis and biochemical characterization that selectivity can be eroded when Tyr118 hy-
drogen bonding is aected. These ndings pave the way in identifying new biocatalysts
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1.1 Biocatalysis
Natural products are an inspiration for the synthesis of therapeutics. The World Health
Organization estimates that approximately 80 percent of the emerging world’s popula-
tion relies on traditional medicines and by 2013 one third of the United States Food and
Drug Administration (FDA)-approved new molecular entities were based on or derived
from natural products. [1, 2] Unfortunately, the synthesis of these molecules is often pro-
hibitively complex, through biocatalysis scientists can synthesize molecules that would
not be accessible through small molecule synthesis. [3] Chemists are inspired by the cat-
alytic tools evolved by Nature to develop eco-friendly routes which have enabled chemists
to synthesize molecules that would not be possible through traditional chemistry. [4] [5]
The bridge between biosynthesis and synthetic chemistry is central in the eld of bio-
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catalysis where enzymes are leveraged in chemical processes to streamline syntheses and
minimize potential hazardous waste. [6] [7] The rst challenge is identifying a biocatalyst
capable of reacting with a variety of substrates. Currently, there are 218 million annotated
protein sequences available in public databases, a number that doubles every 28 months,
and just like the deep seaoor, only a minuscule portion of this territory has been ex-
plored. [8]
1.2 Flavin Dependent Monooxygenases as Biocatalysts
Each cDNA sequence encodes for a protein with a unique composition and order of
amino acids that dictate its fold, and in the case of an enzyme, the reactions it can cat-
alyze. However, predicting a function based on the amino acid sequence is not an easy
feat. Typically, the function has been experimentally determined through labor-intensive
protein expression and isolation coupled with experimental characterization of enzymes
from primary metabolism and natural product biosynthetic pathways. [9, 10]
Enzymes and their function can be distributed into dierent classes depending on
their fold which also dictates the reaction that these enzymes can perform. In Flavin-
dependent enzymes, each of the classes have a canonical enzyme used as guide for classi-
cation. Well-characterized enzymes have historically served as benchmarks for predicting
the function of uncharacterized enzymes. For example, avin-dependent monooxygenase
(FDMO) can mediate various transformations depending on the amino acids in their ac-
tive site. Class A avin adenine dinucleotide (FAD)-dependent monooxygenases mediate
the hydroxylation of substrates. [11] The fold is characterized by having one nucleotide-
binding site occupied by the FAD also reected in the sequence by the GXGXXG mo-
tif. [12,13] Class A FDMOs are dened by being “cautious” enzymes [14], starting catalysis
with avin reduction after substrate binding (Fig. 1.1) and (Fig. 1.2). Accommodating the
substrate in the active site before the reaction occurs is critical in mediating the site- and
enantioselectivity of the product. This binding will trigger a change in conformation in
2
the FAD. The FAD is usually located in the active site and this conformation is denotated
as the "in" conformation. [15] When the FAD swings by a 30◦ it gets exposed to solvent
and the electron source, the conformation is denoted as "out". [15] After substrate bind-
ing, a change in conformation from the “in” to the “out” conformation is triggered. In the
“out” conformation the avin is reduced after accessing the electron source, Nicotinamide
adenine dinucleotide phosphate (NADPH), or Nicotinamide adenine dinucleotide (NADH)
(Fig. 1.1). [16] Reduced avin (FADH2) reacts readily with molecular oxygen to form the
C4a-hydroperoxyavin $$ (1.4) intermediate which reacts with the substrate to
form the hydroxylated product (Fig. 1.1), or can eliminate a molecule of hydrogen perox-
ide to form oxidized FAD (Fig. 1.1). The catalytic cycle is then closed by the elimination of
water from the C4a-hydroxyavin to regenerate FAD.
Figure 1.1: Class A Flavin Dependent Monooxygenases Catalytic Cycle.
Class A FDMOs share a structurally similar nucleotide-binding site to the class B FD-
MOs; however, they have fundamental structural and mechanistic dierences. Class B also
3
known as “bold” enzymes [14] can start catalysis in the absence of the substrate Fig. 1.2.
Class B enzymes have two nucleotide-binding sites, for the FAD and the NAD(P)H. The
catalytic cycle is started by NAD(P)H binding and subsequent reduction of the FAD. The
enzyme-NADP complex quickly reacts with oxygen to form the C4a-hydroperoxyavin
which is remarkably stable (approximately 5 min) compared to the millisecond-scale life-
time found in class A monooxygenases. [14] This stability is due to the NADP-bound in
the active site, which is released after the product is formed. After the substrate is bound to
the active site, hydroxylation of the substrate is performed through a nucleophilic attack
from the FADHOOH to the substrate.
Figure 1.2: Comparison of Class A and B Flavin Dependent Monooxygenases substrate
binding. Top panel showcases class A FAD-dependent monooxygenases characterized by
the rst step, substrate binding. This forms the Enzyme-substrate complex which later is
exposed to NAD(P)H to reduce the FAD. Bottom panel showcases Class B FAD-dependent
monooxygeases highlighting that substrate binding is preceded by FAD reduction.
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1.3 Nature’s Tools For Oxidative Dearomatization Of Resorcinol
Compounds
Figure 1.3: Nature’s tools for oxidative dearomatization of resorcinol compounds.
The site- and stereoselectivity of class A FMDOs during hydroxylation provides an ef-
cient route to valuable enantio-enriched intermediates for the synthesis of natural prod-
ucts with medicinal value with several signicant advantages over conventional synthetic
methods. [17, 18] For example, recent work from our group has demonstrated that the
avoproteins TropB [19], AzaH [20], and SorbC [21] achieve the rapid conversion of a
number of phenolic substrates to dearomatized products (Fig. 1.3). [22] Although TropB
shares a high sequence identity with AzaH and AfoD, 43 percent and 38 percent, respec-
tively, AzaH generates products with the same conguration as TropB, while AfoD installs
the oxygen with the opposite stereoselectivity (Fig. 1.3). Additionally, TropB, AzaH, and
AfoD have complementary substrate scopes. For example, TropB does not tolerate bulky
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substitutions at the C5 or C6 position, except for phenyl at the C6 position, while AzaH ac-
commodates these substrates seamlessly (Fig. 1.3). While AfoD handles similar substrates
as AzaH, the opposite stereocenter can be accessed. Lastly, SorbC has evolved orthogonal
site- and facial-selectivity, hydroxylating the C5 position to yield the dearomatized prod-
uct. This orthogonal selectivity and complementary substrate scope provide an excellent
opportunity to employ these biocatalysts with a breadth of substrates. In contrast to tra-
ditional chemical transformations, in which site-selectivity is dictated by the substrate,
these enzymes exhibit catalyst control over site- and stereoselectivity. [23]
1.4 Proling Function Across Sequence Space
To expand our current library of class A FDMOs we need to predict function and
mechanism based on experimental ndings on these enzymes coupled with the amino
acid sequence ngerprint. Although this approach can lead to accurate function assign-
ments in some cases [24], there other instances in which enzymes possess slightly altered
motifs and can be overlooked in such a function assignment. Through our previous work
on enzyme characterization, benchmarks for enzyme function prediction can be set to
construct a sequence similarity network (SSN). [25] Sequence similarity networks might
provide a framework for identifying enzymes that act on specic substrates classes and
for surveying regions of sequence space where the substrate preference is unknown.
Recently, there has been an evolution of the tools available for canvassing and identi-
fying the sequence space with untapped synthetic potential. Some of the commonly used
tools for sequence proling and visualization are multiple sequence alignments [26], phy-
logenetic trees [27], and sequence similarity networks [25](Fig. 1.4). Additionally, other
visualization tools are being developed such as the variational autoencoder latent space
model. A variational autoencoder (VAE) provides a single value for each encoding dimen-
sion in the latent space using probability. This tool coupled with machine learning can
organize a set of sequences with certain properties in mind like stability. [28]
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Figure 1.4: Tools for sequence proling from left to right: multiple sequence alignment,
phylogenetic tree, sequence similarity network, and variational autoencoder latent space
model.
In a multiple sequence alignment, three or more protein sequences that have some evo-
lutionary connection are aligned (Fig. 1.4). This proling can be used to identify functional
relationships among sequences. This approach highlights conserved residues and motifs
that can potentially be used to predict enzyme function or pinpoint residues that might
be important for enzyme function. Phylogenetic trees, as previously mentioned, indicate
the relationship between sequences across evolution (Fig. 1.4). The branching pattern of
these trees reects how proteins may have evolved from a series of common ancestors.
This tool can illuminate which sequences within a family are most related and distin-
guish close cousins from distant relatives. However, performing family-wide proling re-
quires an accurate large-scale sequence alignment, which can be challenging. Visualizing
sequence relationships for family-wide proling can be cumbersome with the methods
previously outlined. Sequence similarity networks are visual tools that were developed to
group protein sequences based on a similarity threshold. [29] Depending on this threshold
for similarity, the sequences can be grouped based on their similarity, which can translate
to their potential reactivity.
SSNs have proven useful for proling other classes of FAD-dependent enzymes to
identify biocatalysts appropriate for target-oriented synthesis. [24, 30] These examples
showcase the synthetic utility of enzymes hiding in plain sight; the sequences are known,
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but their reactivity will remain a mystery without dedicated experimental work toward
family-wide reactivity proling. These eorts are guided by tools for visualizing sequence
space and have the potential to bring light to the deep seaoor of unexplored enzymes.
1.5 Dissertation Objectives
To develop the FDMOs as synthetic tools, we must dene structural features that gov-
ern substrate binding, the critical catalytic residues, and how these features translate to
other FDMOs. With this information, I will (1) modulate the site- and stereoselectivity of
the biocatalyst as needed by altering a relatively small number of amino acids and (2) nd
and identify other biocatalysts to leverage for the manufacture of natural product building
blocks. Such biocatalytic tools will provide an ecient route to valuable enantioenriched
intermediates for the synthesis of bioactive molecules. Work toward this goal is outlined
in Chapters 2 and 3.
In Chapter 2, I recently demonstrated that a avin-dependent monooxygenase, TropB,
maintains high levels of site- and stereoselectivity across a range of structurally diverse
substrates. [22] I outlined the structural basis for substrate binding in TropB, which per-
forms a synthetically challenging asymmetric oxidative dearomatization reaction with
exquisite site- and stereoselectivity across a range of phenol substrates, providing a foun-
dation for future protein engineering and reaction development eorts. Our hypothesis
for substrate binding is informed by a crystal structure of TropB and molecular dynam-
ics simulations with the corresponding computational TropB model and is supported by
experimental data. Our data indicates that the phenolate form of the substrate binds in
the active site. Furthermore, the substrate position is controlled through two-point bind-
ing of the phenolate oxygen to Arg206 and Tyr239, which are shown to have distinct and
essential roles in catalysis. Arg206 is involved in the reduction of the avin cofactor, sug-
gesting a role in avin dynamics. Further, QM/MM simulations reveal the interactions
that govern the facial selectivity that leads to a highly enantioselective transformation.
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Thus, the structural origins of the high levels of site- and stereoselectivity observed in
reactions of TropB across a range of substrates are elucidated, providing a foundation for
future protein engineering and reaction development eorts. [31]
In Chapter 3, the TropB ndings are extrapolated to other class A FAD-dependent
monooxygenases. I did a sequence proling surrounding TropB to predict the potential.
From this compendium of enzymes I selected an enzyme with predicted complementary
stereoselectivity to that of TropB. A sequence analysis comparison of AfoD and TropB
suggested that the residues critical for activity in TropB were in complementary locations
in AfoD. I hypothesized that these residues are critical for the complementary stereoselec-
tivity in AfoD. In this chapter, I crystallized AfoD, and through a sequence and structural
analysis, then identied and probed the residues that might be critical for stereo- and
site-selectivity. Using a sequence similarity network (SSN), several sequences have been
selected based on their domain and selectivity. I initially chose seven enzymes to evalu-
ate their reactivity and selectivity. Based on this approach, I identied enzymes with the
complementary site- and stereoselectivity. [30] These ndings showcase how sequence
proling coupled with experimental results can be leveraged to identify biocatalysts with
interesting bioactivity. I predict that this approach can be used to canvas and identify new
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Summary
I recently demonstrated that a avin-dependent monooxygenase, TropB, maintains high
levels of site-and stereoselectivity across a range of structurally diverse substrates. In this
chapter, I describe the structural basis for substrate binding in TropB, which performs a
synthetically challenging asymmetric oxidative dearomatization reaction with exquisite
site- and stereoselectivity across a range of resorcinol substrates, providing a foundation
for future protein engineering and reaction development eorts. Our hypothesis for sub-
strate binding is informed by a crystal structure of TropB and molecular dynamics sim-
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ulations with the corresponding computational TropB model and is supported by exper-
imental data. In contrast to canonical class A FAD-dependent monooxygenases in which
substrates bind in a protonated form, the data indicate that the phenolate form of the sub-
strate binds in the active site. Furthermore, the substrate position is controlled through
two-point binding of the phenolate oxygen to Arg206 and Tyr239, which are shown to
have distinct and essential roles in catalysis. Arg206 is involved in the reduction of the
avin cofactor, suggesting a role in avin dynamics. Further, QM/MM simulations reveal
the interactions that govern the facial selectivity that leads to a highly enantioselective
transformation. Thus, the structural origins of the high levels of site- and stereoselectiv-
ity observed in reactions of TropB across a range of substrates are elucidated, providing
a foundation for future protein engineering and reaction development eorts.
2.1 Introduction
The demand for biocatalytic transformations is growing as chemists recognize the
advantages of these processes, including high levels of selectivity, low catalyst loadings,
environmentally benign reagents, and excellent sustainability proles. [7] For transfor-
mations that pose a challenge to traditional chemical synthesis, there is a greater interest
in developing biocatalytic methods. The oxidative dearomatization of phenols to gener-
ate quinol products is a reaction that presents a substantial selectivity challenge using
traditional chemical methods see 2.1 to 2.2, Fig. 2.1. [32] A suite of I(III), I(V), Cu(I), and
Pb(IV) reagents have been developed for oxidative dearomatization. [32–36] In these re-
actions, a phenolic substrate is activated as an electrophile, which is intercepted by an
oxygen nucleophile in either an intra- or intermolecular fashion. [37–39] Achieving high
levels of selectivity in this reaction is desirable as site-selectivity is often substrate- rather
than catalyst-controlled. Further, controlling stereoselectivity under catalytic conditions
remains a challenge. [33, 39–43]
For example, Maruoka and co-workers recently reported an Indane-based organoio-
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Figure 2.1: Chemistry of avin-dependent monooxygenase TropB. Oxidative phenol
dearomatization mediated by TropB in stipitatic acid biosynthesis (see 2.1 to 2.2) and sub-
strate scope. Non-native substrates with perturbation of a single substituent compared to
the native substrate (2.1, blue) were evaluated for reactivity with TropB, measured in total
turnover numbers (TTNs); maximum TTN = 1000 in this assay.
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dine catalyst that provides p-quinol products in up to 84% enantiomeric excess (ee), the
highest stereoselectivity for catalytic oxidative dearomatization reported to date. [43] An-
ticipating that a biocatalyst could provide exceptional selectivity and a superior sustain-
ability prole, I recently investigated the substrate scope and scalability of a panel of
avin-dependent monooxygenases that mediate oxidative dearomatization reactions in
various secondary metabolite pathways. [22] In contrast to traditional chemical transfor-
mations in which site-selectivity is governed by the substrate, selectivity in the avin-
dependent monooxygenase reaction is dictated by the orientation of the substrate in the
active site relative to the oxidant, C4a-hydroperoxyavin (2.12). [11, 14] I envisioned
that a suite of avin-dependent monooxygenases could provide complementary selec-
tivity and redene the state-of-the-art method for mediating this transformation. An ini-
tial study demonstrated that three biocatalysts, TropB, AzaH, and SorbC, perform well
in preparative-scale reactions on a range of substrates while maintaining high levels of
site- and stereoselectivity, providing a single product in 94% to >99% ee. [22] For exam-
ple, TropB oxidizes non-native substrates such as 2.3-2.11, which vary signicantly in
electronic and steric properties compared to the native TropB substrate 2.1, yet for each
substrate a single product is generated in ≥98% ee Fig. 2.1. [22]
I aim to enhance the synthetic utility of these biocatalysts by expanding the substrate
scope, developing a suite of catalysts with complementary selectivities, and accessing
non-native mechanistic pathways. However, to accomplish these goals and fully realize
the synthetic potential of TropB and related enzymes, a structural and mechanistic un-
derstanding of this highly selective biocatalyst is required. I solved a crystal structure of
TropB, which indicated that the active site is suciently spacious to accommodate a range
of substrates but must maintain a conserved binding orientation to achieve high site- and
stereoselectivity across an array of substrates. To provide a detailed understanding of the
active site architecture, substrate binding pose, and residues required for catalysis, molec-
ular dynamics simulations were carried out with a corresponding computational enzyme
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Figure 2.2: A) TropB dimer, with monomer 1 colored in indigo with disordered residues
81-86 shown as a dashed line and monomer 2 shown in gray; (B) TropB crystal structure
overlaid with the TropB QM/MM model with substrate 2.1.
model, and detailed characterization of wild type TropB alongside several variants re-
vealed distinct roles for two amino acids in the active site.
2.2 Structure of TropB
As a rst step toward elucidating the structural basis for selectivity, I solved a crys-
tal structure of TropB to a resolution of 1.7 Å with its avin adenine dinucleotide (FAD)
cofactor bound Fig. 2.2 A and Table 2.2. TropB crystallized as a dimer, consistent with a
dimeric form observed by size-exclusion chromatography Fig. 2.20. The large dimer inter-
face (1244 Å2 of buried surface area) includes 14 salt bridges and 6 additional hydrogen
bonds. The overall structure comprises two domains: (a) FAD-binding domain 1, a typical
class A avin-dependent monooxygenase with a nucleotide binding site for the adenosine
diphosphate (ADP) moiety of the cofactor, and (b) catalytic domain 2 with a binding site
for the isoalloxazine ring Fig. 2.24A and Fig. 2.25A [11]. Part of the interdomain loop be-
tween U4 (domain 1) and V4 (domain 2) is disordered residues 81-86, Fig. 2.2A. Two long
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helices (U11 and U12) also connect domains 1 and 2. A molecule of FAD sits in the narrow
interdomain cleft, with a planar isoalloxazine ring that is consistent with the observed
yellow color of crystals Fig. 2.24. FAD contacts the protein through a combination of hy-
drogen bonds and van der Waals interactions. The adenosine and pyrophosphate groups
are bound to TropB as in other class A FAD-dependent monooxygenases. [44] The isoal-
loxazine ring sits in a binding pocket formed by Pro329, His330, and His331 with hydrogen
bonds of O4 and N3 to Ala55, N1 to Ala335, and O2 to the Cys336 amide. A chloride ion
sits in a tight pocket between the isoalloxazine ring and Pro329, Gly332, and Gly334, as
in other FAD class A monooxygenases Fig. 2.24A. [13, 45, 46]
In the structure of TropB crystallized in the absence of substrate, a large cavity adja-
cent to the isoalloxazine ring is anticipated to be the site of substrate binding. This site
is dened by several side chains (Arg206, Leu226, Met228, His235, Ile237, Tyr239, Ala250,
Phe252, Pro329, His330, His331, and Tyr397), some of which are conserved in other class
A avin monooxygenases. [45] One molecule of hexanediol, a component of the crys-
tallization solution, was bound in the cavity, based on well-dened electron density Fig.
2.3.
Figure 2.3: Bound FAD with omit electron density (green contours at 3.0 f)
As crystallization with the avin cofactor in the oxidized state should permit formation
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of a substrate complex that cannot further react in the crystal, signicant eort was dedi-
cated to obtaining crystals of a TropB ternary complex with FAD and the native substrate,
3-methylorcinaldehyde (2.1). Crystal-soaking and cocrystallization experiments with 2.1
or structural analogues of 2.1 resulted in maps with new electron density in the active site
cavity; however, despite extensive experimentation, none of the conditions explored led to
well-dened density for a single orientation of the substrate or to the full displacement of
hexanediol from the cavity. Although full occupancy of a TropB ternary complex was not
captured, crystallization in the presence of 2.1 induced a change in position of the cofactor
isoalloxazine ring, consistent with avin dynamics of class A avin-dependent monooxy-
genases Fig. 2.4. [14, 15] Substrate binding in class A avin-dependent monooxygenases
triggers avin reduction by inducing a "avin-out" conformation, in which the avin is ac-
cessible to the reduced cofactor, nicotinamide adenine dinucleotide phosphate (NADPH)
or nicotinamide adenine dinucleotide (NADH). [15, 47, 48] The TropB crystal structure
obtained in the absence of substrate depicts the oxidized cofactor in the "avin-in" con-
formation, whereas the structure in the presence of substrate indicated partial occupancy
of a avin-out conformation Fig. 2.4. This change in avin position upon substrate binding
would allow for reduction of FAD to FADH2 by an external reductant (NADH or NADPH),
consistent with other class A avin-dependent monooxygenases. [49, 50]
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Figure 2.4: Electron density for avin in the “in” and “out” conformations. As in other
class A FAD-dependent monooxygenases, [15, 47, 48] substrate binding triggers avin re-
duction by inducing a “avin-out” conformation in which the avin is accessible to the
reduced nicotinamide adenine dinucleoide phosphate (NADPH). Omit electron density
(green contours at 2.5 f) is shown for FAD and substrate 2.1.))
2.3 Substrate Binding and Catalysis
Arg206 and Tyr239 are the only amino acids in the TropB active site that possess rel-
evant functional groups and are near the avin cofactor and partially occupied substrate
site. In the absence of clear density to illustrate the contacts of the native substrate (2.1),
I sought to draw an analogy to substrate complexes of other class A avin-dependent
monooxygenases of known structure. TropB has a low sequence identity to other class
A avin-dependent monooxygenases, except for SalH (31%); [44] nonetheless, structural
features involved in either substrate binding or catalysis remain constant across enzymes
in this class Figs. 2.14 to 2.15. In p-hydroxybenzoate hydroxylase (PHBH) a hydrogen
bond network composed of Tyr201, Tyr385, His72, and a conserved water molecule is
responsible for substrate binding and further catalysis. [14] This network is absent in
TropB; however, Tyr239 and Arg206 are within hydrogen bonding distance of the sub-
strate in the TropB active site. Additionally, the Arg206 guanidinium group is in a po-
sition analogous to the Arg220 guanidinium group in PHBH. This is also the case for
other class A monooxygenases, phenol 2-monooxygenase (PHHY) (Tyr289, Arg287), [52]
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Figure 2.5: Activity of wild type TropB and TropB variants. (A) Substrate 2.1 binding
to wild-type TropB; (B) NADPH depletion upon binding of 2.1; (C) product 2.2 forma-
tion; (D) formation of peroxide in shunt pathway. *Reaction conditions: 2.5 mM substrate
2.1, 2.5 `M TropB variant, 1 mM NADP+, 5 mM glucose-6-phosphate (G6P), 1 U ml−1
glucose-6-phophate dehydrogenase (G6PDH), 50 mM potassium phosphate buer pH 8.0,
30 °C, 1 h. 0% conversion indicates that no substrate consumption or product formation
was detected. **Reaction Conditions: 100 nM TropB variant, 250 `M NADPH, 125 `M 1
monitored at 362 nm over 1000 s. ***Concentration of hydrogen peroxide was measured
using an established assay. [51]
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3-hydroxybenzoate hydroxylase (MHBH) (Tyr271, Arg262), [53] and Salicylate hydroxy-
lase (SalH) (Arg190). [44] This led us to hypothesize that Tyr239 and Arg206 might be
involved in substrate binding and perhaps catalysis.
A set of TropB variants was generated to probe the role of Tyr239 and Arg206 in sub-
strate binding. Arg206 was substituted with either Glu (R206E) or Gln (R206Q) and Tyr239
was replaced with Phe (Y239F) to probe the role of hydrogen bonding in substrate binding
2.2, Fig. 2.18, and Fig. 2.21. TropB R206E, TropB R206Q, and TropB Y239F produced no de-
tectable product by UPLC-PDA analysis under conditions where the wild type TropB led
to complete consumption of the substrate with a specic activity of 0.33 `mol<8=−1<6−1
Figs. 2.5 and 2.19 - 2.25, and 2.35. These results indicate that Arg206 and Tyr239 each have
a critical role in achieving productive catalysis.
Having established that TropB R206E, TropB R206Q, and TropB Y239F produce no
detectable product with the native substrate, 3-methylorcinaldehyde (2.1), we sought to
identify which step of the catalytic cycle was disrupted. TropB binding of 2.1was detected
by the change in absorbance at 492 nm, revealing a Kd of 21 ± 2 `M for wild-type TropB
and 32 ± 4 `M for TropB R206Q Figs. 2.5 and 2.36-2.38. Substituting Arg206 or Tyr239
with an amino acid that cannot act as a hydrogen bond donor led to a signicant increase
in Kd values, suggesting that hydrogen bond donors at positions 206 and 239 are critical
for substrate binding. Next, we investigated whether NADPH can reduce FAD to FADH-
in each TropB variant in the presence of substrate by monitoring NADPH absorbance at
362 nm. Complete consumption of NADPH was observed in 800 s with wild type TropB,
and partial consumption of NADPH was observed with TropB Y239F over 1000 s Fig.
2.5 and Fig.2.42. Additionally, the reduction rate of TropB Y239F was signicantly slower
compared to that of the wild-type, but no product formation was detected in Fig. 2.43.
However, no depletion of NADPH was detected for TropB R206Q or R206E. Thus, we in-
creased the enzyme concentration by 200-fold, and under forcing conditions we observed
partial consumption of NADPH at extended time periods Fig. 2.44. [51] Previously Ballou
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and co-workers demonstrated that the corresponding Arg residue (Arg220) in PHBH is
involved in the avin dynamics required for FAD to toggle from the “in” conformation to
the “out” conformation for reduction to FADH- by stabilizing the “out” conformation. [47]
To test the ability of each TropB variant to react with molecular oxygen to form the la-
bile C4a- hydroperoxyavin intermediate 2.12, an intermediate corroborated by stopped-
ow analysis in Fig. 2.47, the hydrogen peroxide concentration was measured in samples
containing each TropB variant with 2.5 mM substrate and NADPH recycling system, gen-
erating a readout on the level of peroxide formed through uncoupling see 2.12 to 2.14, Fig.
2.5D. In this assay, relatively low levels of H2O2 were measured (0.2 mM) with wild type
TropB, whereas, signicantly higher concentrations of H2O2 were present in reactions
with TropB Y239F (1.4 mM), indicating a higher level of uncoupling in the in vitro reac-
tion. In reactions with TropB (R206E and R206Q), trace amounts of H2O2 were detected
(0.03 mM), which did not increase over time, further indicating that these substitutions
hindered avin reduction Fig. 2.46. Characterization of the Arg206 and Tyr239 variants
support the role of these two amino acids in substrate binding. These results indicate
that Arg206 is also important for FAD reduction to FADH2 and that Tyr239 stabilizes the
substrate in a position suitable for rapid reaction with labile C4a-hydroperoxyavin. Ad-
ditionally, TropB R206Q and TropB Y239F were crystallized. In the TropB Y239F structure,
Phe239 maintains the same position as Tyr239 in the wild-type protein Fig. 2.27, 2.1. In the
crystal structure of TropB R206Q, Gln206 is ordered and unavailable to stabilize FAD in
the “out” conformation, thus, aecting avin reduction in the catalytic cycle Fig. 2.26, 2.1).
Next, we considered which additional residues could be critical for a productive re-
action. Deprotonation is a common step for other class A avin-dependent monooxyge-
nases, and it is generally accepted that this class of monooxygenases requires a catalytic
base for deprotonation of phenolic substrates in order to obtain a suciently nucleophilic
reactant. [11,45,54] Deprotonation is thought to occur prior to avin reduction or during
substrate hydroxylation. [14] In the case of TropB, His235 has been predicted to act as
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Figure 2.6: Hypotheses for substrate activation and positioning. (A) The mechanism on
the right requires deprotonation of the substrate in the active site, which has been pro-
posed to be performed by His235. [55] The mechanism proposed on the left relies on
binding of the anionic form of the substrate, including interactions with Arg206 and
Tyr239 consistent with our experimental ndings. The C4a-hydroperoxoavin Odistal is
highlighted in red. (B) Initial velocity rates for TropB wild-type and the histidine variants.
a catalytic base; [55] however, the crystal structure indicates that His235 is too far from
the substrate to perform a deprotonation. The apparent lack of a basic residue near the
anticipated site of substrate binding led us to hypothesize that the substrate binds as the
phenolate, eliminating the requirement a base to initiate catalysis as previously suggested
Fig. 2.6 A. [56, 57]
To test this hypothesis, we rst investigated the protonation state of the substrate un-
der the reaction conditions, specically the optimum pH 8.28. The protonation state of the
native substrate (2.1) was monitored by UV absorbance, as the phenolate absorbs at 336
nm, whereas, the protonated form is characterized by a maximum absorbance at 292 nm
in Fig. 2.40 - 2.41. This indicates that, under the reaction conditions at pH 8, the predomi-
nant form of the substrate is the anionic form (2.13) with an experimentally determined
pKa of 7.1. To experimentally test the proposal that H235 is necessary for catalysis Fig.
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2.6A, [55] TropB H235A was generated in Fig. 2.19. Substitution of His235 with Ala pro-
duced a catalytically active TropB variant with 10% conversion of substrate to product,
Figs. 2.7 - 2.8.
Figure 2.7: Reaction of 2.1 and TropB H235A. PDA traces of enzymatic reaction.
Figure 2.8: Reaction of 2.1 and TropB H235A. LC-MS trace.
To probe the role of neighboring His residues, His330 and His331 were substituted with
Ala, aording an active variant capable of 11% and 71% conversion of substrate to dearo-
matized product, respectively, Figs. 2.9 to 2.12. Since these residues are close together, one
could imagine His235 and His330 having a redundant function as the requisite base. Thus,
a double substitution was performed to generate H235A/H330A, and the variant remained
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active 10% conversion, Figs. 2.13 and 2.14.
Figure 2.9: Reaction of 2.1 and TropB H330A. PDA traces of enzymatic reaction.
Figure 2.10: Reaction of 2.1 and TropB H330A. LC-MS trace.
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Figure 2.11: Reaction of 2.1 and TropB H331A. PDA traces of enzymatic reaction.
Figure 2.12: Reaction of 2.1 and TropB H331A. LC-MS trace.
Figure 2.13: Reaction of 2.1 and TropB H235A/H330. PDA traces of enzymatic reaction.
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Figure 2.14: Reaction of 2.1 and TropB H235A/H330. LC-MS trace.
These results are consistent with substrate binding in the anionic form, eliminating the
need for a basic residue in the active site for substrate deprotonation. Further, the initial
rates of reactions with 2.1 and wild-type TropB, TropB H331A, or TropB H235A/H330A
follow the reactivity trend with wild type TropB and TropB H331 having initial velocities
of 2.9 and 3.0 `M <8=−1 , respectively Fig. 2.6B. The TropB H235A/H330A variant has a
decreased initial velocity, 0.24 `M <8=−1, that corresponds with the lower conversions
observed in reactions with this variant Fig. 2.48. These data indicate that the His residues
are not required for catalysis but they contribute to an ideal active site environment.
2.4 Computational Approaches To Elucidate the Substrate Bind-
ing Pose
To provide additional insight into the orientation of the native substrate 1 in the ac-
tive site, we turned to computational analysis Experiments and analysis in this section
was performed by collaborators Dr. Troy Wymore and Sara Tweedy at Dr. Charles Brooks
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III lab at the University of Michigan, Ann Arbor. Several enzyme-substrate models with
the avin cofactor as either FAD (2.14) or C4a-hydroperoxyavin (2.12) were evaluated
with ligand-protein docking calculations that use the CDocker protocol. [58] The protocol
employs (i) exible active site side chains and a soft-grid representation of the remaining
receptor during multiple rounds of simulated annealing followed by (ii) geometry opti-
mizations with the CHARMM molecular mechanical force eld and (iii) scoring of the
complexes with the force eld and an implicit solvent model. In addition, molecular dy-
namics (MD) simulations were performed using the docked complexes in explicit solvent
using classical force elds and hybrid quantum quantum mechanical/molecular mechan-
ical (QM/MM) methods. Flexible docking of 2.1 in the anionic form (see 2.13) to TropB
with the avin cofactor in either the oxidized or hydroperoxy form led to a favorable,
low-energy pose consistent with the known site- and stereoselectivity of the reaction.
This docking indicated that both Arg206 and Tyr239 hydrogen bond with the phenolate
oxygen of 2.13 Fig. 2.2B and Fig. 2.6A. The pose showed a signicant change in the loca-
tion of the Arg206 side chain from its position in the crystal structure, while the movement
of Tyr239 was minimal Fig. 2.2B and Fig. 2.49. The displacement of Arg206 is reasonable
given that the enzyme was crystallized with the avin in the oxidized “in” state and must
go through several catalytic steps before reaching the C4a-hydroperoxyavin state, (12)
Fig. 2.5. The charge distribution in the molecular mechanics (MM) force eld delocalized
the negative charge on the substrate in accordance with the gas phase and solvated QM
calculations and was not concentrated on the phenolate oxygen. This indicates that the
interaction with Arg206 and Tyr239 was not driven by an unphysical electrostatic inter-
action that could arise if the charges were overly localized by standard charge distribution
methods.
To characterize enzyme-substrate contacts, several MD simulations of the identied
docking pose were performed. Specically, models with dierent tautomeric states of
His235, His330, and His331 were constructed since the tautomeric states of His residues
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are not directly observed in crystal structures, and these states can be challenging to ac-
curately predict. During each of the 25 ns simulations, the substrate exhibited only min-
imal uctuations (0.24 to 0.65 Å root-mean-square deviation (rmsd) from average atomic
position), remaining in a bound position (averaging 5.2 to 6.8 Å for the Odistal-C3 dis-
tance, Figs. 2.53 - 2.55 and 2.3. A reactive conguration was observed in 1.3% of the snap-
shots as strictly dened by (1) an Odistal-C3 distance less than 4 Å and (2.2) an Odistal-
C3-C3methyl angle between 60◦ and 115◦ Fig. 2.54. All of these snapshots showed a hydro-
gen bond between the anionic substrate 2.13 and Arg206, and approximately half of the
snapshots also showed a hydrogen bond with Tyr239, supporting the relevance of this
interaction. [59, 60] One of the Arg206 terminal amine groups hydrogen bonded to the
phenolate oxygen throughout the simulation (average O-H distance 2.0 Å, 88% of frames
<2.4 Å). Interestingly, the phenolic proton of Tyr239 formed a tighter hydrogen bond as
the simulation progressed. The average distance for this hydrogen bond was 2.7 Å over 24
ns but averaged 2.0 Å in the nal 10 ns with 90% of the snapshots showing a distance less
than 2.4 Å Fig. 2.57. Thus, MD simulations with a classical force eld suggest that both
Arg206 and Tyr239 form hydrogen bonding interactions with the substrate. To investi-
gate the interactions between the substrate and the active site environment with a more
accurate description, MD simulations were also performed using a QM/MM representa-
tion. [61] These simulations were performed by the Dr. Charles Brooks III lab specically
Dr. Troy Wymore and Sara Tweedy. In DFTB3 simulations, water molecules adorn the
polar region of the active site, separating His235 from the substrate. Thus, neither a di-
rect nor Grotthaus-like mechanism for substrate activation by His235 would be feasible.
The substrate maintained hydrogen bonding interactions with both Tyr239 and Arg206
throughout these simulations.
The combined knowledge from the TropB crystal structure and subsequent MD sug-
gests that the anionic form of the substrate, phenolate 2.13, is the predominant form un-
der the reaction conditions and that the negative charge is stabilized through interactions
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with both Arg206 and Tyr239, thus positioning the substrate for a productive reaction
with the C4a-hydroperoxyavin cofactor 2.12,Fig. 2.6A) and leading to a highly site- and
stereoselective transformation.
2.5 Computational Insights on Facial Selectivity
To identify the factors controlling facial selectivity we turned to computation. Ex-
periments and analysis in this section was performed by collaborators Dr. Troy Wymore
and Sara Tweedy at Dr. Charles Brooks III lab at the University of Michigan, Ann Ar-
bor. While QM/MM simulations indicated that hydrogen bonding of Arg206 and Tyr239
with the phenolate form of the substrate is the dominant intermolecular interaction Fig.
2.58, these interactions alone are insucient to be the basis of for the facial selectivity
observed experimentally. Additional interactions between substrate and TropB were ob-
served in MD simulations. Both hydrophobic C3 and C6 methyl groups of substrate 2.1
interacted with hydrophobic residues Fig. 2.58. The C6 methyl group was near Ala55 and
the phenyl group of Phe119. In contrast, the C2 hydroxyl group was positioned in a sol-
vated environment, hydrogen bonding exclusively with the aldehyde moiety Fig. 2.61 -
2.61. If the opposite face of the substrate were presented to the C4a-hydroperoxyavin
factor (2.12) by rotating along the C1- C4 axis, the C2 hydroxyl group would occupy an
unsuitable hydrophobic region and the C6 methyl group would be in a hydrophilic space,
placing these two groups in uncomplementary environments Fig. 2.15A and Fig. 2.63. Sim-
ilarly, the C3 methyl group makes hydro-phobic contacts with Phe252, Ala250, and Ile237.
If the substrate rotated about the C1-C4 axis, however, this methyl group would sit near
the backbone carbonyl of Gly53 and the hydroperoxy group of the avin Fig. 2.62. Thus,
this region would be an energetically unfavorable position for the hydrophobic C3 methyl
group if the substrate presented the opposite face to the cofactor. The bulkier methyl group
would also clash with Tyr239, disrupting the hydrogen bond with the substrate. Thus, we
conclude that the facial selectivity in the hydroxylation of substrate 1 in TropB arises from
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Figure 2.15: QM/MM simulation of the native substrate (2.1) in the active site to illus-
trate facial selectivity. (A) Left: Substrate 2.1 (orange) bound in the active site, showing
favorable contacts with Ala250 and Ile237. Right: 180◦ degree rotation along the C1-C4
axis of 2.1 (green), illustrating unfavorable substrate orientation. (B-D) Substrate docking
of 2.3, 2.8, and 2.7, respectively, with the correct face presented to the avin.
the amphipathic active site environment as illustrated in Fig. 2.15A. Docking of non-native
substrates revealed binding poses analogous to native substrate 2.1 Fig. 2.15B and D and
Fig. 2.50 - 2.51. For example, substrates 2.3 and 2.8 adopt a similar pose to native sub-
strate 2.1, occupying the same space in the TropB active site and maintaining hydrogen
bond interactions with Arg206 and Tyr239 Fig. 2.15B, C, respectively. Substrates with sig-
nicantly more sterically demanding substituents such as 2.7 provide docking solutions
with the substrate slightly shifted in the active site to accommodate bulky substituents
but maintain the relevant hydrogen bonding contacts and facial selectivity as observed
for the native substrate Fig. 2.15D. These docking results are consistent with the site- and
stereoselectivity observed in reactions with non-native substrates. [7]
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2.6 Conclusion
Through structural insights gained from both the crystal structure and molecular dy-
namics simulations, we have uncovered the origins of the exquisite site- and stereose-
lectivity exhibited in reactions of TropB with a breadth of substrates. A crystal structure
of TropB has enabled computational studies that support binding of the anionic form
of the substrate, which is further supported by experimental data. Molecular dynamics
simulations and characterization of TropB variants demonstrated that the phenolate sub-
strate has signicant interactions with both Arg206 and Tyr239, controlling the pose of
the substrate within the active site and the selectivity observed in subsequent reactions.
The excellent stereo-selectivity observed in reactions with TropB can be attributed to
pronounced facial selectivity in substrate binding. These ndings clearly illustrate the
structural features that control the site- and stereoselectivity in the complexity-generating
reaction mediated by TropB, critical for future protein engineering and reaction develop-
ment eorts with TropB and related enzymes.
2.7 Experimental
I. Cloning, protein expression and purication
General Considerations
Escherichia coli (E. coli) cloning strains DH5U (Invitrogen) were used for DNA prop-
agation. Phusion HF polymerase was purchased from New England BioLabs. All primers
were purchased from Integrated DNA Technologies (IDT) ddH2O was sourced from a
MilliQ Biocel water purication unit from Millipore.
Sequence Information
A gene encoding TropB (DAA64700.1) was codon-optimized for overexpression in E.
coli synthesized by GeneArt (Thermosher). GeneArt cloned the synthesized sequence
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into pET151 vector conferring the T7 expression system, ampicillin resistance, and an N-
terminal 6x His tag encoded upstream from the inserted gene. No further modication to
the construct was necessary.
Codon-Optimized tropB Sequence
Figure 2.16: Codon-Optimized tropB Sequence [31]
TropB Protein Sequence
Figure 2.17: TropB Protein Sequence [31]
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Site-directed mutagenesis
Table 2.1: Primer Sequences
TropB(Y239F), TropB(R206Q), TropB(R206E), TropB(R206K), TropB(H235A), TropB(H331A),
TropB(H330A), and TropB(H235A/H330A). Substitutions were generated by site-directed
mutagenesis on pET151-tropB(WT). 25 `L PCR reaction mixtures contained 5 `L of 5X
Phusion HF buer, 1 ng/`L WT parent plasmid, 0.5 `M of primer, 200 `M dNTPs, 0.5 U
`!−1 Phusion HF. Amplication was accomplished with the following PCR protocol: 98 ◦C
for 0:30 s, (98 ◦C 0:10, Tm -5 ◦C 0:30 s, 72 ◦C 0:30/kb) for 25 cycles, with a nal extension
of 72 ◦C for 10:00 min. This was followed by a 10 `L digestion containing 1 `L of NEB
CutSmart buer, 8 `L of PCR mixture and 20 units of DpnI. The reaction was incubated
at 37 ◦C for 3 h and transformed into chemically competent E. coli DH5U cells.
Protein Expression and Purication
Protein overexpression: TropB WT, Y238F, R206Q, R206E, H331A, H330A, H235A/H330A:
Plasmids were transformed into E. coli strain BL21(DE3). 500 mL of Terric Broth (TB)
containing 100 `g<!−1 ampicillin was inoculated with 5 mL overnight culture prepared
from a single colony in Luria Broth (LB) and 100 `g<!−1 ampicillin. Culture was grown
at 37 ◦C and 250 rpm to an OD600 = 0.8. The culture was then cooled to 18 ◦C for 1 h at 200
rpm and protein expression was induced with 0.1 mM isopropyl-V-D-1-thiogalactopyranoside
(IPTG) and expressed at 20 ◦C for 18 h at 200 rpm. After overnight expression, cultures
were centrifuged at 13,881 x g for 30 min. Cell pellets from overexpression were stored at
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-80 ◦C for long-term storage.
General purication procedure: Cell pellets from overexpression were resuspended
in 40 mL of lysis buer (50 mM Tris:HCl pH 7.8, 300 NaCl, 10 mM imidazole, and 10% (v/v)
glycerol) with 0.1 mg <!−1 lysozyme, 0.05 mg <!−1 DNase, and 0.1 mM avin adenine
dinucleotide (FAD), incubated on a rocker at 4 ◦C for 45 min, and lysed by sonication.
Insoluble material was removed by centrifugation (46,413 x g for 30 min). Supernatant
was sterile ltered through a 0.45 `M syringe lter. The claried lysate was loaded onto
a 5 mL HisTrap column (GE Healthcare) on a Healthcare ÄKTA FPLC. The column was
washed with 10 column volumes (CV) of lysis buer, and the protein was eluted with a
8-100% gradient of elution buer (50 mM Tris:HCl pH 7.8, 300 mM NaCl, 400 mM imi-
dazole, and 10% (v/v) glycerol). Fractions containing protein, which were visibly yellow,
were concentrated to 2 mL using a 30 kDa centrifugal cuto lter at 4,000 x g, 4 ◦C. Con-
centrated proteins were further puried by size exclusion chromatography (HiLoad 16/60
Superdex S200, GE Healthcare) in gel ltration buer (50 mM Tris:HCl pH 7.8, 100 mM
NaCl, 10% (v/v) glycerol). Estimated molecular weight including the 6x His tags for TropB
and variants, 50.8 kDa, was conrmed by SDS-PAGE analysis Fig. 2.18. TropB eluted as a
dimer with an apparent molecular weight of 102 KDa and was concentrated to 20.3 mg
<!−1 (Pierce 660nm assay, Thermo Scientic). FAD content was measured by the avin
incorporation assay. [62]
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Figure 2.18: Puried TropB, TropB R206Q, TropB 206E, and TropB Y239F, SDS-PAGE gel.
The gel was stained with Quick Coomassie stain (Anatrace) and visualized with the Azure
Gel Imaging System.
Figure 2.19: Puried TropB Wild-typeTropB, TropB H331A, TropB H235A, and TropB
H330A, TropB H330A/H235A SDS-PAGE gel. The gel was stained with Quick Coomassie
stain (Anatrace) and visualized with the Azure Gel Imaging System.
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TropBH235A: The cell pellet was resuspended in 40 mL lysis buer (50 mM Tris:HCl
pH 7.8, 300 NaCl, 10 mM imidazole, 10% (v/v) glycerol) with 0.1 mg<!−1 lysozyme, 0.05 mg
<!−1 DNase, and 0.1 mM FAD, incubated on a rocker at 4 ◦C for 45 min, lysed by sonication
and cleared by centrifugation (46,413 x g for 30 min). The supernatant was incubated with
Ni-NTA on a rocker for 2 h at 4 ◦C, followed by purication by gravity using a 25-50
mM gradient with increments of 5 mM imidazole. Protein was eluted with 100% elution
buer (50 Mm Tris:HCl pH 7.8, 300 mM NaCl, 400 mM imidazole, 10% (v/v) glycerol).
Concentrated protein was desalted over a PD-10 desalting column (GE Healthcare). The
protein was concentrated further using a 30 kDa centrifugal concentrator at 4,000 x g, 4
◦C. Concentrated protein was divided into 100 `L aliquots, frozen in liquid nitrogen and
stored at -80 ◦C
For crystallization: Protein was dialyzed overnight at 4 ◦C in 50 mM Tris pH 7.8, 50
mM NaCl. After dialysis, proteins were incubated with 500 `M FAD.
Oligomeric state determination: Separations were conducted as described in re-
spective purication procedures using a Sephacryl S-200 HR gel ltration column. Ap-
proximate sizes were determined relative to a calibration curve generated using the Gel
Filtration Standards Kit (Sigma). Where the calibration curve is dened by:
~ = 10(−0.7496(G/39.88)+3.068) (2.1)
Where Y volume that is extrapolated to the column calibration curve and X is the peak
volume of the desired protein. The apparent molecular weight of TropB was 95 kDa. Based
on this analysis, it can be concluded that TropB forms a dimer in solution.
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Figure 2.20: Size-exclusion elution prole of TropB
Determination of avin incorporation: Samples of each protein were diluted to
20 `M using gel ltration buer (50 mM Tris:HCl pH 7.8, 100 mM NaCl, 10% (v/v) glyc-
erol) for UV-Vis analysis in a disposable poly(methyl 2-methylpropenoate) cuvette. The
absorbance spectrum for each protein was taken using a SpectraMax M5 UV-Vis (Molec-
ular Devices). Scans were taken from 300-700 nm in 2 nm increments Fig. 2.21. 40 `L of a
fresh 10% SDS solution (w/v) was added to each 1 mL solution, mixed and boiled at 100
◦C for 10 min. Absorbance of the denatured enzyme was taken from 300-700 nm in 2 nm
increments Fig. 2.21. Absorbance at 450 nm for denatured protein and the extinction coef-
cient (11,300"−12<−1) for free FAD were used to determine the concentration of FAD in
each protein sample using Beer’s law. The typical FAD incorporation for each protein was
TropB 80%, TropB Y239F 90%, TropB R206Q 87%, and TropB R2066E 96%. This percent-
age was multiplied by the value obtained from the Pierce 660 assay to attain the correct
protein concentration.
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Figure 2.21: FAD incorporation comparison of native and denatured protein.
II. Protein crystallization and structure determination
Crystallization: Diraction-quality crystals of wild type TropB were grown by sitting-
drop vapor diusion at 20 ◦C from a solution containing 1 `L protein stock with 0.65%
Dimethyl sulfoxide (DMSO) and 2 `L reservoir solution (1.11 M ammonium tartrate diba-
sic, 6% hexanediol). Crystals of the substrate 2.1 complex were grown under identical
conditions with the inclusion of 4 mM substrate 2.1 in the protein stock. TropB Y239F
was crystallized as the wild type TropB without DMSO. TropB R0206Q was crystallized
also without DMSO in a mixture of 1 `L protein stock and 3 `L reservoir solution. All
crystals were ash-cooled in liquid nitrogen without additional cryoprotection.
Structure determination and renementTropBWT: Diraction data were recorded
at GM/CA beamline 23-ID-B at the Advanced Photon Source (APS), integrated with XDS
[63] and scaled in Aimless [64] in the CCP4 suite [64] 2.2. The structure was solved by
molecular replacement using Phaser [65] with avin-dependent salicylate hydroxylase
(PDB code 5EVY) [44] as a search model by truncating the non-equivalent side chains
to alanine and deleting surface exposed loops. An 87% complete model was obtained us-
ing Phenix AutoBuild. [66] Further model building was carried out in Coot. [67] The -
nal model includes amino acids 11-447 in each TropB monomer. Residues 1-10 at the N-
terminus and an internal loop (81-86) are disordered and not included in the model 2.2. The
dimer model also includes 2 FAD cofactors, 2 hexanediol molecules, 2 chloride ions, and
481 water molecules. Figures were made with Pymol [68], buried surface areas were cal-
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culated with the PISA server [69], and the electrostatic surface potential with APBS. [70]
The stereochemical quality of the structure was validated with MolProbity. [71] The struc-
tures of the substrate 2.1 complex and the R206Q and Y239F variants were solved from
the wild type free enzyme structure. Substrate binding was deleterious to crystal quality
and limited our ability to interpret details in the active site. Crystals of the R206Q and
Y239F variants were signicantly smaller than those of wild type TropB, which limited
diraction quality.
Chloride binding: Electron density in a tight pocket between the FAD isoalloxazine
ring and Pro329, Gly332 and Gly334 was attributed to the presence of a chloride ion Fig.
2.23. This is the predicted binding site for the molecular oxygen substrate. Several other
FAD-dependent monooxygenases can be inhibited by chloride or show competitive inhi-
bition respect to NAD(P)H. [45, 72, 73]
Figure 2.22: TropB sequence alignment with SALH (BAA61829.1), SorbC(XP002567552),
and AzaH(G3XMC2.1). TropB amino acids subjected to mutagenesis are starred. Align-
ment is colored by conservation.
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Figure 2.23: Structural alignment of SALH (5EVY) [44] in gray and TropB in deep blue.
Highlighting comparison of catalytic residues in SALH compared to TropB.
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Table 2.2: Crystallographic Summary, 1Values in parentheses pertain to the outermost
shell data
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Figure 2.24: FAD binding site. (A) Bound FAD with omit electron density (green contours
at 3.0 f) and hydrogen bonds (black dashed lines) to the protein. (B) TropB avin binding
site colored according to electrostatic potential (red to blue from - kT/e to + kT/e).
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Figure 2.25: FAD binding site. Overall structure of TropB and chloride binding in the
active site cavity. (A) Ribbon diagram of the TropB monomer colored as a rainbow from
the blue N-terminus to the red C-terminus. (B) TropB active site with substrate 2.1, its
natural substrate, modeled. A chloride ion sits in a tight pocket between the isoalloxazine
ring and Pro329, Gly332 and Gly334, as in other FAD class A monooxygenases.
Figure 2.26: Comparison of wild-type TropB (green) and TropB R206Q (cyan). The
Arg206 points towards the FAD, while the Gln side chain points towards the backbone
and is not able to hydrogen bond with the FAD in the out conformation.
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Figure 2.27: Comparison of wild type TropB (green) and TropB Y239F (cyan). The Phe239
points in the same direction as Tyr239 residue.
III. Biocatalytic Reactions
General Considerations: A stock solution of the substrate (50 mM) was prepared
by dissolving the substrate in DMSO (analytical grade). Stock solutions of NADP+ (100
mM) and glucose-6-phosphate (G6P, 500 mM) in water were stored at -20 ◦C. Aliquots
of glucose-6-phosphate dehydrogenase (G6P-DH, 100 U<!−1), TropB and variants were
stored at -80 ◦C.
In vitro analytical-scale reactions: Each reaction contained 50 mM of potassium
phosphate buer pH 8.0 (25 `L, 100 mM stock), 2.5 mM substrate (2.5 `L, 50 mM), 1 mM
NADP+ (0.5 `L, 100 mM), 1 mM G6P-DH (0.5 `L, 100 u<!−1), 5 mM G6P (5 `L, 5 mM),
and Milli-Q water to a nal volume of 50 `L. Reactions were carried out at 30 ◦C for 1
h and quenched with the addition of 70 `L acetonitrile (HPLC grade) containing 2.5 mM
pentamethylbenzene as an internal standard. Reactions were cleared by centrifugation at
16,000 x g, 12 min) and the supernatant was analyzed by UPLC-DAD. Consumption of the
starting material was quantied by comparison to standard curves of each substrate.
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Substrate Calibration Curve:
Figure 2.28: Calibration Curve of substrate 2.1.
UPLC traces of Biocatalytic Reactions
Figure 2.29: Oxidative dearomatization of 2.1 by TropB WT. PDA traces of enzymatic
reaction. IS = internal standard.
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Figure 2.30: No enzyme control of the reaction of 2.1. PDA traces of enzymatic reaction.
Figure 2.31: Reaction of 2.1 and TropB R206Q. PDA traces of enzymatic reaction.
Figure 2.32: Reaction of 2.1 and TropB R206E. PDA traces of enzymatic reaction.
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Figure 2.33: Reaction of 2.1 and TropB Y239F. PDA traces of enzymatic reaction.
Figure 2.34: Reaction of 2.1 and TropB WT, TropB Y239F, or hydrogen peroxide. PDA
traces of enzymatic reaction and control reactions.
Note: In the Fig. 2.33 there is a peak with a retention time of 2.024 min with maximum
absorbance of 265 nm. This peak does not have the corresponding absorption spectrum
of the dearomatized product- but that of the Baeyer-Villiger product shown below in Fig.
2.34. This product is formed due to a high concentration of hydrogen peroxide gener-
ated by this variant. This is further conrmed by a no enzyme control run with 2.5 mM
hydrogen peroxide.
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Figure 2.35: Summary of in-vitro reactions. Average percent conversion calculated from
reactions in triplicate and compared to calibration curve of substrate 2.1.
IV. Biochemical Characterization of TropB WT and Variants
Substrate binding titrations with TropB WT, TropB (R206Q), TropB (R206E), and TropB
(Y239F). All spectral binding measurements were carried out on a UV-2501PC spectropho-
tometer (Shimazu). Spectral binding titrations of substrate 2.1 were performed at 4 ◦C in
50 mM phosphate buer pH 8.0 using 1 mL volume samples containing 20 `M enzyme in
a 1 cm pathlength cuvette. Substrate 1 stock solutions were made at 3-14 mM in 100 mM
phosphate buer pH 8.0. Titrations were performed step wise additions of the substrate
2.1. After each addition the cuvette was sealed with a Teon stopper and mixed 5 times
slowly. UV-Vis spectra (300-700 nm) were recorded for the ligand-free enzyme and follow-
ing each addition of substrate. Substrate additions were continued until no further shifts
in the spectrum occurred or 500 `M substrate 2.1 was reached. A turbidity correction was





A dierence spectrum was generated at each stage in the titration by subtraction of
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the spectrum from the ligand-free enzyme spectrum for each subsequent ligand-bound
form of substrate [Substrate 1:FAD-dependent monooxygenase] spectrum produced. The
wavelengths of the largest absorbance changes were identied from the dierence spectra,
and a maximal induced absorbance change Δmax at each point in the titration was deter-
mined by subtracting the absorbance at the wavelength minimum from the absorbance
maximum, using the same wavelength pair for each titration. Δmax values were plotted
against ligand concentration, and data were t using either a cooperative binding (The
Hill equation) function, to determine dissociation constants (Kd values), as described pre-
viously. All data processing was done using GraphPad Prism software.
Figure 2.36: Binding titration of TropB WT. (A) Binding titration of TropB WT corrected
for turbidity with Rayleigh equation. The substrate-free (20 `M) is shown with a thick
solid blue line. Thin solid lines show spectra collected after stepwise additions of substrate
2.1 from a (3 mM-14 mM stock). The nal spectrum (collected at 500 `M substrate 2.1)
is near saturated with substrate. (B) Plot of the dierence spectra. (C) Substrate-induced
absorbance dierence against the relevant concentration of substrate 2.1 at 492 nm.
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Figure 2.37: Binding titration of TropB R206Q (A) Binding titration of TropB R206Q cor-
rected for turbidity with Rayleigh equation. The substrate-free (20 `M) is shown with a
thick solid blue line. Thin solid lines show spectra collected after stepwise additions of
substrate 2.1 from a (3 mM–14 mM stock). The nal spectrum (collected at 500 `M sub-
strate 2.1) is near saturated with substrate. (B) Plot of the dierence spectra. (C) Substrate-
induced absorbance dierence against the relevant concentration of substrate 2.1 at 492
nm.
Figure 2.38: Binding titration of TropB Y239F. (A) Binding titration of TropB Y239F cor-
rected for turbidity with Rayleigh equation. The substrate-free (20 `M) is shown with a
thick blue solid line. Thin solid lines show spectra collected after step wise additions of
substrate 2.1 from a (3 mM–14 mM stock). The nal spectrum (collected at 500 `M sub-
strate 2.1) is near saturated with substrate. (B) Plot of the dierence spectra. (C) Substrate-
induced absorbance dierence against the relevant concentration of substrate 2.1 at 492
nm.
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Figure 2.39: Binding titration of TropB R206E. (A) Binding titration of TropB R206E cor-
rected for turbidity with Rayleigh equation. The substrate-free (20 `M) is shown with a
thick blue solid line. Thin solid lines show spectra collected after step wise additions of
substrate 2.1 from a (3 mM–14 mM stock). The nal spectrum (collected at 500 `M sub-
strate 2.1) is near saturated with substrate. (B) Plot of the dierence spectra. (C) Substrate-
induced absorbance dierence against the relevant concentration of substrate 2.1 at 492
nm
Substrate 2.1 spectra at various pH values: All spectral substrate measurements
were carried out on a SpectraMax M5 UV-Vis (Molecular Devices). 2.5 mM of substrate
2.1 (50 mM, DMSO stock) was diluted in 1 mL 50 mM potassium phosphate buer pH
2.1 at 22 ◦C. Substrate was titrated to the following pHs (2.6, 3.0, 3.5, 4.3, 5.0, 5.6, 6.0, 6.5,
7.1, 7.8, 8.9, 9.6,10.5). UV-Vis scans were taken at each titration point to generate Fig. 2.40.
Scans were taken from 250-700 nm in 2 nm increments. Absorbance of the phenol and the
phenolate were plotted against the pH. The inexion point was calculated to determine
that the pKa of the substrate is 7.1 Fig. 2.41.
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Figure 2.40: Native substrate 2.1 titration with potassium phosphate.
Figure 2.41: Native substrate 2.1 titration with potassium phosphate.
Depleation of NADPH in of TropB WT and variants: All spectral measurements
were carried out on a UV-2501PC spectrophotometer (Shimazu). Addition of NADPH was
done at 25 ◦C. Reaction conditions: 50 mM phosphate buer pH 8.0, 100 nM enzyme,
250 `M NADPH and 125 `M substrate 2.1 was carried out in a 1 cm pathlength cuvette.
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Depletion of NADPH was measured at 362 nm for 1000 sec.
Figure 2.42: NADPH depletion assay monitored at 362 nm.
Reductive half-reaction for TropBWT: The reaction of TropB WT and TropB Y239
was studied in a Hi-Tech Scientic KinetAsyst SF-61 DX2 Stopped-ow spectrophotome-
ter at 4 ◦C. Enzyme solution was made anaerobic in a tonometer in the presence of 200
`M substrate 2.1 and mixed with anaerobic solutions of NADPH at dierent concentra-
tions. [74] Kinetic traces were t to a single exponential using GraphPad PRISM. The
observed rate constants for avin reduction were plotted vs. NADPH concentration and
tted to a square hyperbola to obtain kred and Kd. [75]
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Figure 2.43: TropB wild type reductive half-reaction.
Reductive half-reaction of TropB R206Qmonitored over time in the presence
of NADH: The reaction of TropB R206Q was studied in UV-2501PC spectrophotometer
(Shimazu) UV-Vis spectrophotometer at 25 ◦C. A 20 `M enzyme solution was prepared
anaerobically in a tonometer in the presence of 125 `M substrate 2.1 and mixed with
anaerobic solution of 250 `M NADH. [74]UV-Vis scans were taken every 2 min for 3.3 h
over 300 nm-700 nm in 1 nm increments. Full reduction of the variant TropB R206Q was
achieved at 3.3 h.
Figure 2.44: TropB R206Q anaerobic reductive half-reaction with NADH monitored over
time.
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Reduction of TropB R206Q: All spectral measurements were carried out on a UV-
2501PC spectrophotometer (Shimazu). Addition of NADPH was done at 25 ◦C. Reaction
conditions: 50 mM phosphate buer pH 8.0, 20 `M enzyme, 250 `M NADPH and 125 `M
substrate 2.1 was carried out in a 1 cm pathlength cuvette. Depletion of NADPH was
measured at 362 nm for 3.3 h Fig. 2.45.
Figure 2.45: NADPH depletion assay monitored at 362 nm with TropB R206Q at 20 `M.
Hydrogen Peroxide Formation Assay: Production of hydrogen peroxide was de-
tected by HRP (2.5 `M) and 4-amino antipyrine (0.75 mM)/2,4,6-tribromo-3-hydroxybenzoic
acid dye (0.02% W/V), phosphate buer pH 8.0 (100 mM). [51] In a 96-well plate, 190 `L
of the assay solution was combined with 10 `L of peroxide (16 `M-3 mM) to generate a
hydrogen peroxide calibration curve. For reactions, 10 `L of a quenched in vitro reaction
was added to 190 `L assay solution to measure hydrogen peroxide production measured
at 510 nm.
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Figure 2.46: NADPH depletion assay monitored at 362 nm with TropB R206Q at 20 `M.
Oxidative half reaction of TropB monitored over time in the presence of O2:
The reaction of 50 `M TropB WT was studied in a Hi-Tech Scientic KinetAsyst SF-61
DX2 Stopped-ow spectrophotometer at 25 ◦C. An anaerobic enzyme solution was pre-
pared in a tonometer in the presence of 50 `M substrate 2.1 and mixed with buer, 50 mM
Tris:H2SO4 pH 7.8, 25 mM Na2SO4 and 10% glycerol containing 20% or 100% O2. The re-
action was monitored at 450 nm to track FAD oxidation. Kinetic traces were plotted using
GraphPad PRISM. The blue bold line represents the reaction with 100% O2 and the orange
dashed trace represent reaction with 20% O2. The rst phase is directly aected by the
concentration of oxygen present. Moreover the formation of these two phases indicates
the formation of FADHOOH. [76]
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Figure 2.47: TropB WT oxidative half-reaction.
Initial velocity of TropB wild-type, TropB (H331A), TropB (H235A/H330A)
with substrate 1: Reaction mixtures were prepared that contained 50 nM enzyme, 5 `M
of substrate 2.1, and 50 mM phosphate buer pH 8 and Mili-Q water to a nal volume
of 50 `L. Reactions were initiated by addition 10 `L of a solution of 1 mM NADPH at
room temperature. Reactions were quenched with 10 `L of a solution of 10% v/v formic
acid in acetonitrile at time points 0, 10, 30, 60, and 300 s. Further, 1.2x dilution with ace-
tonitrile was performed to precipitate protein in solution. The reaction was cleared by
centrifugation at 17,000 x g for 12 min. The supernatant was analyzed by LC-MS (TOF).
The consumption of the starting material was quantied by comparison to a standard
curve of substrate 2.1 and internal standard (1,2,4-trimethylbenzene).
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Figure 2.48: (A) Starting material (1) area under the curve divided by internal standard
area under the curve plotted over time for enzymatic reactions initiated with NADPH and
quenched with 10% v/v formic acid. (B) Initial velocity plots of TropB wild-type, TropB
(His331), and TropB (His235A/H330A). (C) Calibration curves used for quantication of
starting material determined by LC-MS (TOF).
57
V. Computational modeling of ligand binding
A. Computational Methods
Docking of Substrate 2.1 to TropB
The protocol for docking substrate 2.1 to the holo-form of TropB with the cofactor in
the oxidized form was as described by Wu et al. using the CHARMM software package.
[77,78] The protocol is also described here due to minor dierences from the initial report.
The TropB-cofactor coordinates were obtained from the crystal structure and the pro-
tons were added with CHARMM-gui according to their canonical protonation states. [78]
The tautomeric state of histidine residues was assigned in order to maximize hydrogen
bonds between protein residues. The hydroperoxyavin coordinates were simply modi-
ed from the reduced avin by adding the hydroperoxy group to C4a on the re face of
the avin. The phenolate form of the substrate Substrate (2.1) was used for docking. Grid
potentials were rst calculated for all xed elements of the receptor with probe radii cor-
responding to the latest CGENFF atom types. [79, 80] Flexible side chains were chosen to
encompass the broad active site surrounding the avin, and included Ala55, Thr57, Leu96,
Trp98, Phe119, Arg206, Leu226, Met228, Iso237, Tyr239, Asn248, Phe252, and Trp426. A
random rotation of the C1-C(aldehyde) bond (the only rotatable bond) was performed
with the “obrotamer” algorithm in OpenBabel. [81] The Substrate (2.1) structure was then
geometry optimized using force eld parameters obtained from ParamChem with slight
adjustments to the charge distribution in agreement with Mulliken charges from quantum
chemical calculations.
The docking cube was centered at the average coordinate of the exible residues,
which were chosen to surround the avin and active site, and the cube dimensions were
dened by the maximum coordinates of the exible residues in each direction plus 10 Å.
The Substrate (2.1) position was then translated within the docking cube and randomly ro-
tated and/or further translated. The structure was then geometry optimized with very soft
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and soft potentials and then removing any complexes with highly unfavorable poses (>200
kcal/mol). At this stage, the substrate, avin, and exible side chains are represented by
the CHARMM force eld while the rest of the model is represented by the pre-computed
grid potentials. A simulated annealing simulation was then performed with very soft and
soft potentials (very soft: 4.5 ps of MD with increasing temperature 300 –>700K and 21 ps
of MD decreasing temperatures 700 –>300K; soft: 10.5 ps of MD with decreasing temper-
ature 500 –>300K and nally 4.5 ps of MD with decreasing temperature 400 –>50K).
Next, the entire model is represented by the CHARMM force eld with a distant de-
pendent dielectric function (n = 3) while geometry optimization is performed with 50 and
100 steps using the Steepest Descent (SD) and Adopted Basis Newton Raphson (ABNR)
algorithms, respectively to predict the docked pose. This protocol was repeated 20 times
for each of the 25 rotamers docked to the oxidized holo-form TropB for a total of 800 and
500 total docked poses respectively.
Final energies were calculated using generalized Born molecular volume (GBMV) im-
plicit solvent model. [82] Docking poses were ranked by total energy of the complex, and
low energy structures consistent with known stereochemical outcome and with a C3 to
hydroperoxyavin Odistal distances < 4 Åwere considered for further analysis of reactive
positioning.
Additional rigid docking analyses were performed for several substrates (2.5, 2.6, 2.9,
2.10 and 2.11) using a slightly modied procedure with no exible residues. These sub-
strates were docked to the TropB protein structure from the productive binding pose iden-
tied during exible docking with the native substrate 2.1. This structure used the fully
oxidized avin model (FAD) and had Arg206 and Tyr239 in a position that would allow
for hydrogen bonding to the substrate. For two of the bulkier substrates, 2.7 and 2.10,
this rigid docking protocol did not sample favorable productive binding poses, so another
round of docking was initiated from the same protein structure, but with residues sur-
rounding the active site made exible (residues Leu96, Trp98, Phe119, Leu226, Met228,
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and Trp426). This exible protocol produced low-energy, productive poses for the bulkier
substrates that were used for analysis. Rigid docking of the native substrate 2.1 was also
performed with TropB variants Y239F, R206Q, and R206E based on the corresponding
crystal structure coordinates.
Molecular Dynamics Simulations of TropB-peroxy-FADH2-Substrate ternary
complex
Select docked structures were subsequently used to construct solvated models. Oxy-
gen atoms identied in the crystal structure as water molecules (TIP3P potential) were
retained in the model with protons being added with the HBUILD program in CHARMM.
[83] Bulk solvent surrounded the entire ternary complex in a cube with the size being the
largest dimension of the protein plus 20 Å. 81 K+ and 78 Cl− counterions were added to
correspond with a 0.15 mol concentration and an overall electrically neutral model. The
active-site chloride ion identied in the crystal structure was also represented though this
ion immediately translates out of the active site during the simulation. The nal model
contained 90761 atoms.
MD simulations were performed with the OpenMM/CHARMM interface in version
c42b1 and using periodic boundary conditions, particle mesh Ewald for long range elec-
trostatic interactions, and a langevin thermostat (W = friction coecient = 5) to maintain
the temperature at 298K. [84] Harmonic restraints of 10.0 kcal mol−1
AA−2 were placed on all non-hydrogen atoms of the solute during the rst 500 ps of the
simulation, which used a 1 femtosecond (fs) timestep. The simulation was continued for
another 24 nanoseconds (ns) with a 2 fs timestep. Simulations were also performed on the
ternary complex with FAD in reduced form for 100 ns using a 1 fs timestep.
DFTB3/MM Simulations
Snapshots from the MD simulation using a classical force eld with the hydroperoxy
group aligned for reaction with the oxyanionic substrate were extracted for further simu-
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lation using a quantum mechanical/molecular mechanical potential energy function. The
DFTB3 method was used for the QM region that included the substrate and the side chains
of R206, Y239, and N248, the isoalloxazine ring of the hydroperoxyavin and seven water
molecules proximal to the substrate. [61] The link atom approach was utilized placing the
link atom for the cofactor between C25 and C25 so that the rst hydroxyl substituent of
the R-group was included in the QM region. The total number of DFTB3 atoms was 125.
A 150* kcal mol−1
AA−2 harmonic restraint was placed on the mass-weighted distance dierence between
the peroxy Od-Op bond and the forming Od-C3 bond (Reaction coordinate = 0.571 * (Od-
Op) – 0.429 * (C3-Od)). The Michaelis complex (where the reactants are lowest in free
energy) is represented by a reaction coordinate value of -0.75 Å(full simulation results to
be presented in a future manuscript). The complex was simulated with the DFTB3/MM
method for 50 ps using a 1 fs timestep. To obtain reliable analysis of the partial charge dis-
tribution, the CHELPG application within ORCA was applied to the minimized Michaelis
complex structure. [85, 86] The calculations were performed using the B3LYP functional
with D3 correction and def2-TZVPP basis set. [87–95] The resulting partial charges are
provided in supporting text les.
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Figure 2.49: Flexible Docking Result for Native Substrate Compared with Crystal Struc-
ture Substrate Density. The favorable productive docking pose is close to the crystal struc-
ture density presumed to be the substrate. The substrate was modeled into the crystal
structure density (transparent green sticks) and shows a 2.1 Åroot-mean-square deviation
(RMSD) from the docking pose (solid orange sticks). The protein is shown in the navy car-
toon, the crystal structure side chains are shown in gray sticks, the docking model side
chains are shown in navy sticks, and the avin is shown in yellow sticks. In contrast,
docking studies with the substrate in the neutral form failed to generate interactions that
could activate the substrate through deprotonation or to orient the substrate in a pose
that would allow for a reaction with the site- and stereoselectivity necessary to generate
the observed product 2.2. Performed by Sara Tweedy.
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Figure 2.50: Rigid Docking Results for the Native Substrate. Graph of calculated binding
energy vs. substrate RMSD from an energetically favorable productive pose (top) and rep-
resentative low-energy poses (bottom) illustrating A) the productive docking pose com-
pared with the substrate modeled from crystal structure density; B) the pose with the
substrate ipped around the C1-C4 axis and presenting the opposite face to the avin;
and C) another energetically favorable pose with the substrate positioned far from the
avin such that hydroxylation with the substrate in this pose would not be productive.
A pose was considered productive if the substrate presented the face consistent with the
known stereochemical outcome and was positioned such that a c4a-hydroperoxy group
on the avin could attack the substrate (i.e. the substrate C3 carbon was 4 - 8 Åfrom the
avin c4a carbon). The avin is represented in yellow sticks and the protein in the navy
cartoon. The crystal structure side chains are represented in grey sticks while the substrate
modeled into the crystal structure density is shown in panel A and represented in trans-
parent lime-green sticks. The substrate poses generated by rigid docking are represented
in orange sticks and the side-chain positions are shown in navy sticks. The productive
docking poses generated by rigid docking of the native substrate also overlap well with
the crystal structure density. The poses consistent with the known stereochemistry (A)
are more energetically favorable than the poses where the substrate presents the opposite
face (B). The other energetically favorable poses generated are non-productive poses with
the substrate far from the avin (C). Performed by Sara Tweedy.
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Figure 2.51: Rigid Docking of Other TropB Substrates with WT TropB. Docking of other
TropB substrates reveals that they behave similarly to the native substrate and substrates
presented in the main text. They form favorable, low energy poses that are consistent
with the stereochemical outcome and preserve phenolate group hydrogen bonding with
R206 with Y239 nearby. Representative, favorable poses are illustrated for substrates A).
2.5; B). 2.6; C). 2.9; and D). 2.11. The pose for each substrate (shown in solid green sticks)
is overlaid against the pose for the native substrate (shown in transparent, orange sticks).
The protein is shown in the navy cartoon, protein residues R206/Y239 are shown in navy
sticks, and the avin is shown in yellow sticks. Performed by Sara Tweedy
A). Substrate docking to the Y239F variant did not reveal the basis for reduced binding
anity as the results closely correspond to those for the native enzyme. Also, the crystal
structure does not indicate that this substitution causes any signicant change in the ac-
tive site or enzyme in general. Thus, our results suggest that some other factor such as a
change in the distribution of productive binding poses corresponding to a conformational
selection model of substrate binding may play a role. In addition, charge transfer from
the substrate to the protein surroundings observed in QM/MM calculations of the native
(Y239) form and that contribute to substrate binding would be reduced in the F239 variant.
Charge transfer eects are not accounted for in the docking calculations.
B). Substrate docking to the R206Q variant resulted in poses with favorable binding
energies of similar magnitude as to the native enzyme. Yet, the poses revealed that the
substrate was not in a position to be hydroxylated by the reactive hydroperoxyavin in-
termediate. This result corresponds with the experimental results that indicate that the
native substrate binds to this variant but that the substrate is not hydroxylated. Thus, a
hydrogen bond donor is important for binding but alone insucient for catalysis.
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C). Substrate docking to the R206E variant resulted in only a small subset of poses
with favorable binding energies of similar magnitude to the native enzyme. In addition,
the few poses with the substrate positioned for hydroxylation were unfavorable compared
to the native enzyme and the R206Q variant. The docking results suggest that binding to
the active site with favorable energetics is less likely than in the native or R206Q and thus
perhaps not sucient to register a change in the spectra that can be observed.
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Figure 2.52: Rigid Docking of TropB Native Substrate with TropB Variants A) Y239F, B)
R206Q, & C) R206E. Performed by Sara Tweedy.
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Figure 2.53: Substrate 2.1 C3-Odistal Distance in MD Simulations. The distance between
the hydroperoxyavin distal oxygen and substrate C3 is plotted versus the simulations
time for 8 molecular dynamics (MD) simulations. Each simulation was initiated from the
same coordinates and docking pose, but had dierent histidine tautomers for histidines
235, 330 and 331 (HSE or ‘E’ with the hydrogen on Nn , HSD or ‘D’ with hydrogen on Nf ,
or the doubly protonated HSP or ‘P’). The histidine tautomers used in each simulation
(for His235/His330/His331 respectively) were: A) HSD/HSD/HSD – maroon; B) HSD/HS-
D/HSE – red; C) HSD/HSD/HSP – orange; D) HSD/HSE/HSP – yellow; E) HSD/HSE/HSE
– green; F) HSD/HSE/HSE – teal; G) HSE/HSD/HSE – blue; H) HSE/HSD/HSP – purple.
Performed by Sara Tweedy
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Table 2.3: Average Odistal-C3 Distance and Substrate RMSD for MD Simulations. The
average distance between the hydroperoxyavin distal oxygen and substrate C3 shown
for each MD simulation. The average root-mean-square coordinate deviation (rmsd) of
the substrate from the average structure is also shown for each simulation. The simula-
tions are labeled by the tautomers used for histidines 235/330/331 respectively, using D
for proton on Nf , E proton on Nn , and P for the positively charged His. Performed by Sara
Tweedy
Figure 2.54: Fraction of MD Simulations Considered Reactive with Dierent Odistal-C3
Distance Cutos. Snapshots were considered reactive if the substrate presented the cor-
rect face to the hydroperoxyavin, angle of approach (Odistal-C3-C3methyl angle between
60◦ and 115◦), and a short distance between reactive entities (hydroperoxyavin Odistal to
substrate C3 distance less than 5.0 Å– blue, 4.5 Å– red, or 4.0 Å– purple). The simulation
with His235 D, His330 E, and His331 D (His D/E/D) was chosen for further analysis based
on the high proportion of reactive frames. Performed by Sara Tweedy
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Figure 2.55: Backbone RMSD of the “D/E/D” MD Simulation. The root-mean-square co-
ordinate deviation (RMSD) of the TropB backbone atoms, not including highly mobile
loop regions (residues 45-55, 80-92, 153-154,190-191, and 255-267), is shown for the sim-
ulation. The RMSD was calculated after the structures were aligned for each frame with
respect to 1) the crystal structure (green line), 2) the initial pose (pink line), and 3) the av-
erage structure (periwinkle line). The average RMSD over the simulation was 1.57 Åfrom
the crystal structure, 0.96 Åfrom the initial pose, and 0.75 Åfrom the average structure.
Performed by Sara Tweedy
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Figure 2.56: Fluctuation of TropB Residues Over “D/E/D” MD Simulation: (Left) The aver-
age root-mean-square coordinate deviation (RMSD) of the backbone atoms for each amino
acid are shown. The RMSD was calculated after the structures were aligned with respect
to 1) the crystal structure (green triangles), 2) the initial pose (pink circles), and 3) the
average structure (periwinkle squares). (Right) The average root-mean-square coordinate
uctuation (RMSF) of the backbone atoms for each amino acid are shown (blue diamonds).
Three mobile loop regions, two mobile loop turns, and the terminal amino acids show the
greatest mobility and deviation from the crystal structure. Mobile loop 1 (residues 80-92)
includes a loop region that has no density in the apo crystal structure and mobile loop 3
(residues 45-55) includes the region that becomes disordered (and loses electron density)
upon substrate addition. Performed by Sara tweedy
Figure 2.57: Hydrogen Bonding Between Substrate Phenolate Group and Arg206/Tyr239
for “D/E/D” MD Simulation: Distances are shown between the substrate phenolate group
and A) Arg206 amine hydrogen (salmon lines), and B) Tyr239 hydroxyl-group hydrogen
(purple lines). Performed by Sara Tweedy
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Figure 2.58: Hydrogen Bonding Between Substrate Phenolate Group and Arg206/Tyr239
for DFTB3/CHARMM Simulations of the Michaelis Complex: For the two analyzed simu-
lations, distances are shown between the substrate phenolate group and A) Arg206 amine
hydrogen (red lines), and B) Tyr239 hydroxyl-group hydrogen (purple lines). Performed
by Sara Tweedy
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Figure 2.59: Nonpolar Contacts of Substrate Methyl Groups in DFTB3/CHARMM Sim-
ulations of the Michaelis Complex: Carbon-carbon distances are shown for the two an-
alyzed simulations over the entire 50ps simulations. In the rst column, distances are
shown between the substrate C6-methyl group carbon and A) center-of-mass of Phe119
ring carbons (pink lines); B) CV of Ala55 (green lines); and C) CU of Gly332 (blue lines). In
the second column, distances are shown between the substrate C3-methyl group carbon
and D) Cn of Phe252 (purple lines); E) CV of Ala250 (green lines); and F) CW2 of Ile237
(orange/brown lines). Performed by Sara Tweedy
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Figure 2.60: Solvation of Substrate C6-Methyl Group Position in DFTB3/CHARMM Sim-
ulations of the Michaelis Complex: The distance between the carbon of the substrate C6
methyl group and the nearest water molecule (dark blue/teal lines) is shown alongside
the distance to one particular water molecule that is predominantly the closest or second
closest water through both analyzed simulations (bright blue/turquoise lines). The near-
est water molecule is more than 2Åaway throughout the simulation, and only one water
molecule is ever within 3.5Å(the second closest is predominantly more than 4.5-5Åaway).
Performed by Sara Tweedy
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Figure 2.61: Intramolecular Hydrogen Bonding of Substrate C2-Hydroxyl Group in
DFTB3/CHARMM Simulations of the Michaelis Complex: The distance between the sub-
strate aldehydic oxygen and hydroxyl hydrogen is plotted alongside the distance between
the hydroxyl hydrogen and the backbone carbonyl oxygen of His330. The C2-hydroxyl
group is shown to be in close contact with the backbone carbonyl oxygen of His330
(tan/brown lines), but remains exclusively hydrogen bonded to the adjacent aldehydic
oxygen (grey/dark grey lines). Performed by Sara Tweedy
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Figure 2.62: The Proximity of the Small C5-Hydrogen to A) Gly53, B) Tyr239, and C)
theReactive Hydroperoxyavin in DFTB3/CHARMM Simulations of the Michaelis Com-
plex: The distance between the C5-hydrogen and the backbone carbonyl of Gly53 (A, top
left) is shown in blue next to the distance between C5-H and the oxygen of the Tyr239 phe-
nol group (B, top right; purple/pink) for both analyzed simulations. Below (C, red/orange
lines) the distance between the C5-hydrogen and the distal oxygen of the hydroperoxy
group is shown alongside the distance to the hydrogen on the hydroperoxy group. The
C5-hydrogen is typically within 3 Åof one of those atoms. A larger and more hydrophobic
substituent at C5, such as a methyl group, would be placed in contact with the hydrophilic
backbone carbonyl, hydroxyl group, and hydroperoxy group. Performed by Sara Tweedy
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Figure 2.63: Interactions between Substrate Substituents and TropB Demonstrating Ba-
sis of Facial Selectivity: (left, A) A DFTB3/CHARMM geometry optimized structure of the
enzyme-avin Michaelis complex is illustrated with the avin represented in yellow sticks,
active-site amino acids represented with grey sticks, water molecules in CPK represen-
tation, and the enzyme mainchain as a blue ribbon. The substrate is depicted as spheres;
carbons are orange. (right, B) positioning with the substrate ipped around the C1-C4 axis.
Coloring as before but with carbons of substrate in pink. In the Michaelis complex, hy-
drophobic contacts between substrate methyl groups and Ala55, Ala250, Phe119, Phe252,
and Ile237 are maintained while the hydroxyl group is positioned in a hydrophilic, sol-
vated region. In contrast, when the substrate is ipped, the hydroxyl group is placed in the
hydrophobic region near Ala55 and Phe119 while the C6 methyl group points toward the
hydrophilic solvated region. In addition, the bulkier C3 methyl group clashes with nearby
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Summary
Selective access to a targeted stereoisomer is often critical to the synthesis of biologically
active molecules. Small-molecule reagents and biocatalysts are routinely available to ac-
cess either enantiomer of a molecule. However, having a biocatalyst that can access the
mirror-image of the same molecule is not readily accessible creating a challenge in the ap-
plication of biocatalysis in synthesis. Here, I report an approach for accessing biocatalysts
with complementary enantioselectivity. An orthogonal approach to protein engineering
was employed using a sequence similarity network (SSN). Through this strategy, I iden-
77
tied enantiocomplementary biocatalysts, like AfoD, and enabled the enantiodivergent
synthesis of natural products and analogs. I solved the structure of AfoD and identied
the residues that have a potential role in determining the stereoselectivity of the prod-
uct. With the sequence proling strategy coupled with experimental data and the crystal
structure of AfoD, I was able to select an FAD-dependent biocatalyst library for further
testing across a panel of substrates.
3.1 Introduction
Isomers can have stark dierences in their biological activities. For example, one enan-
tiomer of the drug thalidomide is sold as a treatment for a wide array of cancers like
myeloma and skin conditions like leprosy, while the other enantiomer causes severe ter-
atogenic eects. [96] This example underscores the importance of developing methods
that can selectively generate single isomers. Oxidative dearomatization is a reaction that
can build complexity and chirality in natural product synthesis by introducing stereocen-
ters in resorcinol scaolds. [22] An example of a natural product that can arise from this
reaction is the azaphilone family. These compounds are characterized by an oxygenated
pyranoquinone bicyclic core bearing a single tetrasubstituted carbon Fig. 3.1. [97–101]
Isolated from fungal sources, this large family of natural products is known to contain a
diverse array of structural features that impart a wide range of biological properties in-
cluding anticancer, [102–104] antiviral, [105] and anti-inammatory activities. [104, 106]
For example, luteusin A (3.6) and rubrotiorin (3.5) were found to inhibit the binding of the
HIV surface glycoprotein gp120 to the human CD4 protein, making these natural products
potential starting points for the development of therapeutic agents against the virus. [105]
In addition, monascin (3.7), a tricyclic azaphilone natural product, has been shown to
down-regulate steatohepatitis in a mouse model, indicating that these secondary metabo-
lites have potential as therapeutics for nonalcoholic fatty liver disease. [107] As illustrated
in Fig. 3.1, azaphilone natural products can contain either the R- or the S-conguration
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Figure 3.1: A. Reaction scheme for the oxidative dearomatization reaction performed by
AfoD and TropB using the C4a-hydroperoxyavin as the oxidant. B. Sequence similarity
network containing with TropB highlighted in gray and AfoD in teal highlighting the
change in residues from AfoD to TropB C. Biologically active azaphilone natural products
feature both the R- and the S-congurations at the C7 stereocenter
at the C7-position. Several cases of epimeric azaphilones are known, in which each C7-
epimer is produced by a distinct fungal source. [108,109] The pharmaceutical potential of
these molecules has been demonstrated through initial in vitro and cell-based assays of
isolated natural products. [110–112]
Furthermore, the application of asymmetric oxidative dearomatization to the synthe-
sis of some tricyclic members of the azaphilone family is yet to be reported. In contrast,
Nature has evolved a highly ecient catalyst suite for oxidative dearomatization, a fam-
ily of avin-dependent monooxygenases (FDMOs) capable of installing a hydroxyl group
with perfect site- and stereoselectivity and with low catalyst loading, mild reaction con-
ditions, with molecular oxygen as the stoichiometric oxidant Fig. 3.1. [11] Selectivity in
this class of enzymes is dictated by the substrate binding mode within the active site, of-
ten resulting in a generation of a single enantiomer of the product. However, access to
both enantiomers is often required to produce scaolds for natural products, requiring
protein engineering and rescreening of enzyme variants to access the desired enantiomer.
A structural and mechanistic understanding of FDMO enzymes can create a blueprint for
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a unied approach to protein engineering strategies and tight biocatalytic control over
stereoselectivity.
Toward this goal,I identied catalysts with complementary selectivity by canvassing
the sequence space surrounding TropB in a sequence similarity network (SSN) of puta-
tive FDMOs. The sequence space around TropB will provide biocatalysts that can perform
similar reactions but with structural dierences that can result in complementary selectiv-
ity outcomes. This method of selection can be leverage for selecting a library that works
across a panel of substrates.
3.2 Sequence Proling of Flavin-Dependent Monooxygenases
To survey how the selectivity of avin-dependent monooxygenases is related by se-
quence, I constructed a sequence similarity network (SSN) of putative avin-dependent
monooxygenases Fig. 3.2A. [25,29,113] SSNs are visual representations of the relatedness
of protein sequences, which cluster on the basis of similarity thresholds. [25] This ap-
proach can enable the rapid and logical investigation of proteins likely to demonstrate sim-
ilar reactivity and/or selectivity, dramatically reducing the time and search space required
during screening, considerations critical to improving the compatibility of biocatalytic
approaches and traditional synthetic strategies. The protein family (Pfam01494) of avin-
dependent monooxygenases includes over 45,000 enzyme sequences, which are included
in the full SSN displayed in Fig. 3.33. This data set was truncated by limiting the search to
edges possessing an alignment score greater than 110, which returned 1211 sequences Fig.
3.2A. We noted that the enzymes we had previously investigated, AzaH, TropB, and SorbC,
were each located in distinct groups or "clusters" within the network, and that a fourth
tight clustering of sequences formed between the TropB and SorbC clusters containing
an enzyme associated with asperfuranone biosynthesis, AfoD. [19, 114, 115] Previous in
vivo studies [115] and bioinformatic analysis [114] indicated that AfoD is responsible for
oxidative dearomatization of an asperfuranone precursor with the same site-selectivity
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as TropB and AzaH; [114] however, the absolute conguration of asperfuranone suggests
that AfoD carries out this transformation with the opposite facial selectivity. [19]
Figure 3.2: (A) Sequence similarity network (SSN) of FAD-dependent monooxygenases
(Pfam01494) using a sequence alignment score of 110. (B) Results of expression, activity
with model substrate 3.11 or 3.14** with R1 = H, and site- and stereoselectivity of enzymes
chosen from the SSN in panel A. *FDMO4 demonstrated <10% conversion by UPLC with
substrate 3.11. (C) Selected clusters from a more stringent SSN generated with an align-
ment score of 150 and corresponding analysis of the multisequence alignment of each
cluster.
Analysis of sequence alignments between each of these clusters revealed conserved
residues at positions 118 and 237 (AfoD numbering), Fig. 3.1B. In general, catalysts that
generate products with the R-conguration possess a tyrosine at position 237 and an aro-
matic residue such as phenyalanine or tryptophan at position 118. In contrast, these con-
served residues switch positions in biocatalysts that aord products with the S-conguration.
We previously demonstrated that a two-point coordination of the phenolate substrate by
Tyr237 and an arginine residue is critical for positioning the substrate within the active
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site in the R-selective enzyme, TropB. [31, 116].
3.3 AfoD Crystal Structure
A sequence alignment of AfoD and TropB revealed that many positions in the substrate-
binding pocket have dierent amino acid side chains. Notably, AfoD possesses a Phe237
analogous to the critical substrate-orienting Tyr239 in TropB. Therefore, to elucidate the
basis for selectivity, we solved a crystal structure of AfoD to a 2.0 Å resolution with bound
avin adenine dinucleotide (FAD) cofactor Fig. 3.3B and 3.2. In contrast to dimeric TropB,
AfoD was monomeric in crystals and in solution Fig. 3.4. Typical of class A FDMOs, AfoD
is composed of a FAD-binding domain with a site for the adenosine diphosphate (ADP)
and a catalytic domain. As expected for proteins with 37 % sequence identity, the overall
structures of AfoD and TropB are similar (RSMD 1.30 Å for 334 CU atoms).
Figure 3.3: AfoD monomer with the avin cofactor highlighted in yellow. Zoom-in of the
active site of AfoD shown with surface contour and overlaid with TropB co-crystallized
with its native substrate PDB: 6NET B. AfoD active site in teal overlaid with TropB
(PDB:6NET) in light grey. C. TropB crystal structure (PDB:) overlaid with computational
model of TropB showcasing the two point binding mode to the substrate engaging Tyr239
and Arg206.
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Figure 3.4: Size-exclusion elution prole of AfoD.
The class A FDMOs employ a “wavin’ avin” mechanism for cofactor reduction in
which the FAD isoalloxazine ring rotates between an “in” position for substrate engage-
ment and an “out” position for reduction by NAD(P)H. [14] To determine which class the
AfoD enzyme belongs to we performed a reaction in the presence and absence of sub-
strate while monitoring the consumption of NADPH. This experiment was to determine
if the addition of substrate is required for cofactor reduction. The NADPH depletion was
monitored at 362 nm, the isosbestic point between the product and starting material. The
reaction was carried out in the presence and absence of substrate. Upon the addition of
substrate to AfoD, the rate of oxidation of NADPH was enhanced suggesting that AfoD
is a class A FDMO Fig. 3.5. In the AfoD crystal structure, the FAD isoalloxazine ring is
in the “out” position where it c-c stacks with Phe297. This is a striking contrast to the
“in” avin position observed in the substrate-free TropB crystal structure. However, sub-
strate is required in both AfoD and TropB to enhance the rate of FAD reduction during
catalysis Fig. 3.5. We hypothesize that Phe297 is less bulky than Trp299 in TropB in an
analogous position which allows freer movement of the FAD cofactor providing a stable
conformation in the AfoD crystals.
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Figure 3.5: NADPH Depletion Assay monitored at 362 nm. Reaction of AfoD without
the presence of substrate. Data is tted to tangent of the curve to determine the rate of
consumption of NADPH.
The sequence identity between TropB and AfoD is 37 percent, therefore the overall
fold is the same with some amino acid changes that might give rise to their distinctive
enantioselectivity. In the active site cavity, Phe237 occupies the position of TropB Tyr239,
whose phenolic group is essential for catalysis. [31] On the opposite side of the AfoD
active site, Tyr118 (Phe119 in TropB) is near the FAD isoalloxazine ring where it could
fulll a similar role that of Tyr239 in TropB Fig. 3.3B. The opposite positions of these
phenolic functional groups render the active sites mirror images of one another and could
be a simple way for Nature to control selectivity.
3.4 Mutagenesis and Catalysis of AfoD
Based on the crystal structures and sequence alignment of AfoD and TropB, AfoD
Tyr118 and Phe237 are potential determinants of substrate positioning in the active site.
To probe the role of these residues in catalysis and in determining facial selectivity, we
generated AfoD variants Y118F and F237Y Fig. 3.6.
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Figure 3.6: AfoD Wild-type, AfoD(Y118F), AfoD(F237Y), SDS-PAGE gel. The gel was
stained with Quick Coomassie stain (Anatrace) and visualized with the Azure Gel Imaging
System. Units in the left side of the image are in kDa
To measure activity, we used the model substrate (3.11) Fig. 3.12, which mimics AfoD
native substrate key moieties but with a shorter C6 aliphatic side chain. AfoD variants
were assayed though analytical in vitro reaction with substrate (3.11) by monitoring sub-
strate consumption by ultra high-performance liquid chromatography coupled to a pho-
todiode array ultra high-performance liquid chromatography coupled to a photodiode ar-
ray (UPLC-DAD) Fig. 3.7A and B. AfoD Y118F and F237Y both possessed catalytic activity
generating product (3.12) that spontaneously cyclizes to (3.13) Fig. 3.7 B and C.
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Figure 3.7: A. Reaction scheme for in vitro reaction with substrate (3.11). B. UPLC- Pho-
todiode Array PhotoDiode Array (PDA) traces highlight the starting material (3.11) and
product (3.13). C. Average percent conversion from in vitro reactions based on the sub-
strate (3.11) calibration curve Fig. 3.8. Reaction conditions: 2.5 mM substrate 3.11, 20 `M
enzyme, 1 mM NADP+ , 5 mM glucose-6-phosphate (G6P), 1 `mL-1 glucose-6-phosphate
dehydrogenase (G6PDH), 50 mM potassium phosphate buer pH 8.0, 30 ◦C, 1 h. C. Aver-
age percent conversion from in vitro reactions based on the substrate (3.11) calibration
curve. *Reaction conditions: 2.5 mM substrate 3.11, 20 `M enzyme, 1 mM NADP+ , 5
mM glucose-6-phosphate (G6P), 1 `mL-1 glucose-6-phosphate dehydrogenase (G6PDH),
50 mM potassium phosphate buer pH 8.0, 30 ◦C, 1 h. IS = internal standard, pentamethyl-
benzene
Figure 3.8: Calibration Curve of substrate 3.11
AfoD wild type has an average conversion of 55% with substrate (3.11) and AfoD
variants Y118F and F237Y 28% and 38% conversion, respectively, Fig. 3.7 C and Fig. 3.10.
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In contrast to TropB, where Phe substitution to the catalytic Tyr239 resulted in no de-
tectable product and hydrogen peroxide generation, the AfoD substitutions generated
equal amounts of hydrogen peroxide compared to AfoD wild type, allowing us to de-
termine the eect of amino acid substitutions on enantioselectivity Fig. 3.30.
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Figure 3.9: PDA traces of AfoD Y118F and AfoD F237Y mediated oxidative dearomatiza-
tion to yield 3.13
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Figure 3.10: Summary of in vitro reactions with substrate 3.11. Reactions were done in
triplicate.
3.5 Evaluation of AfoD variants stereoselectivity
Analysis of sequence alignments between each of these clusters revealed conserved
residues at positions 118 and 237 (AfoD numbering). In general, catalysts that generate
products with the R-conguration possess a tyrosine at position 237 and an aromatic
residue such as phenyalanine or tryptophan at position 118. In contrast, these conserved
residues switch positions in biocatalysts that aord products with the S-conguration Fig.
3.2 C. We previously demonstrated that a two-point coordination of the phenolate sub-
strate by Tyr237 and an arginine residue is critical for positioning the substrate within the
active site in the R-selective enzyme, TropB. [31, 116] To probe the role of Tyr118 in the
stereoselectivity provided by AfoD, the AfoD Y118F and F237Y variants were generated.
Both AfoD single variants were reacted with resorcinol 3.11 in preparative-scale reactions
to generate isolable quantities of product 10. I previously reported that the AfoD wild-type
and Y118F yielded the dearomatized product in 1:99 and 53:47 [30] (S:R) enantiomeric ratio
enantiomeric ratio (er), respectively, (Fig. 3.11 and Fig. 3.30), highlighting the importance
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of Tyr118 in controlling facial selectivity in the binding site of AfoD. However, with AfoD
F237Y, the dearomatized product was formed in 29:71 (S:R) er (Fig. 3.11). AfoD F237Y has
a phenolic functional group in the analogous position to the catalytic TropB Tyr239, but
also has a second phenolic group at Y118 on the opposite side of the active site Fig. 3.3 B.
I hypothesize that this led to the formation of some R enantiomer, as formed by TropB.
Figure 3.11: Representation of substrate interaction with residues in the active site of
the AfoD wild-type and single variants with the enantiomeric ratio across dierent AfoD
variants. Preparative–scale enzymatic reactions were conducted on 10 mg of substrate
(3.11) under the following conditions: 20 `M enzyme, 1 mM NADP+ , 5 mM glucose-6-
phosphate (G6P), 1 `mL-1 glucose-6-phosphate dehydrogenase (G6PDH), 50 mM potas-
sium phosphate buer pH 8.0, 30 ◦C.
3.6 Flavin-Dependent Monooxygenase Library
We hypothesized that sequences with high similarity to TropB, AzaH, AfoD, and SorbC
would encode enzymes that possess the ability to carry out oxidative dearomatization re-
actions, and further questioned if trends in site- and stereoselectivity could be predicted
on the basis of sequence. To test this hypothesis, seven sequences were selected on the
basis of proximity to either TropB, AzaH, AfoD, or SorbC in the SSN labeled FDMO1 to 7
in Fig. 3.2A. Synthetic genes corresponding to the four known enzymes and FDMO1 to 7
were transformed into E. coli BL21(DE3) cells. Under standard expression conditions, nine
proteins were successfully obtained, whereas FDMO1 and FDMO3 proved insoluble un-
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der these conditions (Fig. 3.2 B). The reactivity of the nine soluble enzymes was evaluated
with two substrates, 3.11 and 3.14 (Fig. 3.12).
Figure 3.12: Model Substrates tested with the FDMO library
Gratifyingly, all nine enzymes showed activity with one of the two model substrates,
eight of which displayed more than 40 percent activity, for product isolation from preparative-
scale reactions (Fig. 3.2 B). A single product was obtained from each biocatalytic reaction,
and a strong trend in site-selectivity was clear from these data: FDMO7, the enzyme most
similar to SorbC, produced C5-hydroxylated product, whereas the remaining enzymes
more similar to TropB, AzaH, and AfoD delivered C3-hydroxylated products. However,
the trend between location on the SSN (Fig. 3.2 A) and stereoselectivity was not apparent.
Increasing the E value from 110 to 150 produced an SSN that provided greater insight
into the relationships between sequences in this family (Fig. 3.34). Notably, previously
clustered sequences associated with divergent selectivity, such as AfoD and FDMO5, now
clearly separated into distinct clusters (Fig. 3.2 C). Analysis of sequence alignments be-
tween each of these clusters revealed conserved residues at positions 118 and 237 (AfoD
numbering).
Beyond the importance of the Tyr position in the active site, it is clear that other
mechanisms for stereocontrol have evolved in this class of enzymes. For example, catalysts
AzaH and SorbC break from this Tyr control mechanism, and, in the case of SorbC, I
have proposed an alternative mechanism for control of substrate position in the active
site. [117] I uncovered that the SorbC enzyme employs hydrophobic pocket to dock the
substrate in the active site using the C1 aliphatic sidechain of the substrate. With AzaH I
have observed it works with more electron decient substrates, therefore basic or acidic
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residues might be involved in the mechanism. Ultimately, this survey of sequence space
surrounding known enzymes provides a greater understanding of the sequence features
that can predict site- and stereoselectivity and has increased the number of biocatalysts
vetted for this transformation.
With this goal in mind I have set to explore 500 putative FMDOs as biocatalysts em-
ploying a sequence and structure-guided approach. This will potentially generate a library
of hydroxylated products across a library of substrates. This approach could lead to curat-
ing more promiscuous enzymes and with complementary activity, but it could also lead to
insoluble biocatalysts or inactive biocatalysts towards or selected substrates. To overcome
this challenge we aim to test challenging enzymes for solubility under our conditions and
test them against a chemically diverse library compared to our traditional substrates.
3.7 Conclusion
Through structural insights gained from the AfoD crystal structure and sequence anal-
ysis, we have uncovered the origins of AfoD stereoselectivity. Facial selectivity is abol-
ished in AfoD Y118F, demonstrating that hydrogen bonding with this residue may be crit-
ical for stereoselectivity. Moreover, AfoD F237Y introduced an additional hydrogen bond-
ing partner in the active site, leading to the formation of the S enantiomer. These ndings
illustrate the structural features that control stereoselectivity in the reaction mediated by
AfoD. These are critical for future protein engineering and the search for catalysts with
complementary stereoselectivity.
A survey of the sequence space of TropB coupled with structural and catalytic nd-
ings provides a greater understanding of the features that can potentially predict the site-
and steoreoselectivity of a number of biocatalysts. This has informed current work in the
Narayan lab to expand the FDMO sequence library implementing a machine learning ap-
proach. This technology informed by experimental data will have the potential to predict
the function of biocatalysts based on their sequence.
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3.8 Experimental
I. Cloning, Protein Expression, and Purication
A. General Considerations
E. coli cloning strains DH5U (Invitrogen) were used for DNA propagation. Phusion HF
polymerase was purchased from New England BioLabs. All primers were purchased
from Integrated DNA Technologies (IDT) ddH2O was sourced from a MilliQ Biocel
water purication unit from Millipore.
B. Sequence Information
A gene encoding afoD (Q5BEJ7.1) was codon-optimized for overexpression in E. coli syn-
thesized by GeneArt (Thermosher). GeneArt cloned the synthesized sequence into pET151
vector conferring the T7 expression system, ampicillin resistance, and an N-terminal 6x
His tag encoded upstream from the inserted gene. No further modication to the construct
was necessary. The plasmid encoding AzaH (G3XMC2.1), in a modied pET28 vector to
aord protein with both C- and N-terminal 6 x His-tags, was a generous gift from Pro-
fessor Yi Tang at the University of California, Los Angeles. The plasmids encoding for
FMDO1-7 were synthesized by Twist Bioscience and cloned into a pET28a vector.
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Figure 3.13: For protein expression we used a codon-optimized AfoD gene that was or-
dered from GeneArt. [30]
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Figure 3.14: Sequence for codon-optimized azaH that was gifted by Professor Yi Tang at
the University of California, Los Angeles. [30]
Figure 3.15: Codon-optimized FDMO1 sequence. [30]
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Figure 3.16: Codon-optimized FDMO2 sequence. [30]
Figure 3.17: Codon-optimized FDMO3 sequence. [30]
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Figure 3.18: Codon-optimized FDMO4 sequence. [30]
Figure 3.19: Codon-optimized FDMO5 sequence. [30]
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Figure 3.20: Codon-optimized FDMO6 sequence. [30]
Figure 3.21: Codon-optimized FDMO7 sequence. [30]
C. Site-directed mutagenesis
Table 3.1: Primer Sequences.
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AfoD(Y118F), AfoD(F237Y). Substitutions were generated by site-directed mutagene-
sis on pET151-afoD(WT). 25 `L PCR reaction mixtures contained 5 `L of 5X Phusion HF
buer, 1 ng/`L WT parent plasmid, 0.5 `M of primer, 200 `M dNTPs, 0.5 U `L-1 Phusion
HF. Amplication was accomplished with the following PCR protocol: 95 ◦C for 30 s, (95
◦C 30s 95 ◦C for 30 s (-0.5 ◦C/cycle), 72 ◦C 0:30/kb) for 12 cycles, (95 ◦C for 30 s, 65 ◦C for
30 s, 72 ◦C 0:30/kb) for 20 cycles with a nal extension of 72 ◦C for 10 min. This was fol-
lowed by a 10 `L digestion containing 1 `L of NEB CutSmart buer, 8 `L of PCR mixture
and 20 units of DpnI. The reaction was incubated at 37 ◦C for 3 h and transformed into
chemically competent E. coli DH5U cells.
D. Gene Expression and Protein Purication
Cell Growth:
AfoD Wild-type, AfoD(Y118F) and AfoD(F237Y), Plasmids were transformed into E.
coli strain BL21(DE3). 500 mL of Terric Broth (TB) containing 100 `g mL-1 ampicillin
was inoculated with 5 mL overnight culture prepared from a single colony in Luria Broth
Luria Broth (LB) and 100 `g mL-1 ampicillin. The culture was grown at 37 ◦C and 250 rpm
for 4 h. The culture was then cooled to 20 ◦C for 1 h at 200 rpm, and expression was induced
with 0.1 mM isopropyl-V-D-1-thiogalactopyranoside (IPTG) and growth continued at 20
◦C for 18 h at 200 rpm. After overnight expression, cultures were centrifuged at 13,881 x g
for 30 min. Cell pellets from overexpression were stored at -80 ◦C for long-term storage.
Protein Purication for Crystallography:
The cell pellet from a 3 L culture was resuspended in 40 mL of lysis buer (50 mM
Tris:HCl pH 7.8, 300 NaCl, 10 mM imidazole, and 10% (v/v) glycerol) with 0.1 mg mL-1
lysozyme, 0.05 mg mL-1 DNase, and 0.1 mM avin adenine dinucleotide (FAD), incubated
on a rocker at 4 ◦C for 2 h, and lysed by sonication. Insoluble material was removed by
centrifugation (46,413 x g for 30 min).
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The soluble fraction was sterile-ltered through a 0.45 `M syringe lter. The claried
lysate was loaded onto a 5 mL HisTrap column (GE Healthcare) on a Healthcare ÄKTA
FPLC. The column was washed with 10 column volumes (CV) of lysis buer, and the pro-
tein was eluted with an 8-100% gradient of elution buer (50 mM Tris:HCl pH 7.8, 300 mM
NaCl, 400 mM imidazole, and 10% (v/v) glycerol). Fractions containing protein, which were
visibly yellow, were concentrated to 2 mL using a 30 kDa cuto lter by centrifugation at
4,000 x g, 4 °C. Concentrated proteins were further puried by size exclusion chromatog-
raphy (HiLoad 16/60 Superdex 00, GE Healthcare) in gel ltration buer (50 mM Tris:HCl
pH 7.8, 100 mM NaCl, 10% (v/v) glycerol). Estimated molecular weight including the 6x
His tags for AfoD wild-type and variants, 48.5 kDa, was conrmed by SDS-PAGE analysis
Fig. 3.6. AfoD wild-type eluted as a monomer with an apparent molecular weight of 48
kDa Fig. 3.4. FAD content was measured by the avin incorporation assay. [62]
Protein Purication for Assay:
The cell pellet was resuspended in 40 mL lysis buer (50 mM Tris:HCl pH 7.8, 300
NaCl, 10 mM imidazole, 10% (v/v) glycerol) with 0.1 mg <!−1 lysozyme, 0.05 mg <!−1
DNase, and 0.1 mM FAD, incubated on a rocker at 4 °C for 45 min, lysed by sonication and
cleared by centrifugation (46,413 x g for 30 min). The supernatant was incubated with
Ni-NTA on a rocker for 2 h at 4 °C, followed by purication by gravity using a 25-50
mM gradient with increments of 5 mM imidazole. Protein was eluted with 100% elution
buer (50 Mm Tris:HCl pH 7.8, 300 mM NaCl, 400 mM imidazole, 10% (v/v) glycerol).
Concentrated protein was desalted over a PD-10 desalting column (GE Healthcare). The
protein was concentrated further using a 30 kDa cuto lter by centrifugation at 4,000 x
g, 4 °C. Concentrated protein was divided into 100 `L aliquots, frozen in liquid nitrogen
and stored at -80 ◦C.
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Oligomeric state determination:
Separations were conducted as described in respective purication procedures using a
Sephacryl S-200 HR gel ltration column. Approximate sizes were determined relative
to a calibration curve generated using the Gel Filtration Standards Kit (Sigma). Accord-
ing to the calibration curve where y =10(-0.7496(x/39.88)+3.068), the apparent molecular
weight of AfoD was 48 kDa. Based on this analysis, it can be concluded that AfoD forms
a monomer in solution.
Determination of avin incorporation:
A 100 `L sample of enzyme stock was boiled at 100 ◦C for 10 min. Solution was claried
by centrifugation. Supernatant was then transferred to a 96-well plate and the absorbance
was recorded from 300-700 nm in 1 nm increments. Absorbance at 450 nm and the extinc-
tion coecient (11,300 M−1 cm−1 ) for free FAD were used to determine the concentration
of FAD in each protein sample using Beer’s law. Due to evaporation, the pathlength was
measured for each well and used in the calculation of FAD concentration. The FAD incor-
poration for each protein was AfoD wild-type 64%, AfoD Y118F 58%, AfoD F237Y 65%.
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Figure 3.22: UV-Vis of denatured AfoD wild-type.
Figure 3.23: UV-Vis of denatured AfoD Y118F.
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Figure 3.24: UV-Vis of denatured AfoD F237Y.
II. Protein crystallization and structure determination
Crystallization:
Diraction-quality crystals of wild type AfoD were grown by sitting-drop vapor dif-
fusion at 20 ◦C from a solution containing 1 `L protein stock and 1 `L reservoir solution
(0.2 M (NH4)2SO4, 0.1 M MES:NaOH pH 6.5, 30% w/v PEG 5K MME). All crystals were
ash cooled in liquid nitrogen without additional cryoprotection. Crystals were sensitive
to radiation.
Structure determination and renement of AfoD wild-type:
Diraction data were recorded at GM/CA beamline 23ID-B at APS, integrated with
XDS [63] and scaled in Aimless [64] in the CCP4 suite [64] table 3.2. The structure was
solved by molecular replacement using Phaser [65] with avin-dependent TropB (PDB
code 6NES) [31] as a search model. Further model building was carried out in Coot and
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renement in Phenix AutoBuild. [66, 67] The nal model includes amino acids 10 - 352
in AfoD monomer. The monomer model also includes 1 FAD cofactor and 279 water
molecules. Figures were made with Pymol. [68] The stereochemical quality of the struc-
ture was validated with MolProbity. [71]
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A stock solution of the substrate (50 mM) was prepared by dissolving the substrate in
DMSO (analytical grade). Stock solutions of NADP+ (100 mM) and glucose-6-phosphate
(G6P, 500 mM) in water were stored at -20 ◦C. Aliquots of glucose-6-phosphate dehydro-
genase (G6P-DH, 100 U<!−1 ), All enzymes in this chapter were stored at -80 ◦C.
In vitro analytical-scale reactions
Each reaction contained 20 `M enzyme, 50 mM of potassium phosphate buer pH
8.0 (25 `L, 100 mM stock), 2.5 mM substrate (2.5 `L, 50 mM stock), 1 mM NADP+ (0.5
`L, 100 mM stock), 1 mM G6P-DH (0.5 `L, 100 ` <!−1 ), 5 mM G6P (5 `L, 5 mM stock),
and Milli-Q water to a nal volume of 50 `L. Reactions were carried out at 30 ◦C for 2
h and quenched with the addition of 70 `L acetonitrile (HPLC grade) containing 2.5 mM
pentamethylbenzene as an internal standard. Reactions were cleared by centrifugation
at 16,000 x g, 12 min) and the supernatant was analyzed by UPLC-diode Array Detector
(DAD). Consumption of the starting material was quantied by comparison to standard
curves of each substrate.
UPLC traces of Biocatalytic Reactions
Figure 3.25:Oxidative dearomatization of S1 by AfoD wild-type. PDA traces of enzymatic
reaction. IS = internal standard, SM = Starting Material 3.11, and PRD = Product 3.13.
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Figure 3.26: No enzyme control of the reaction of S1. PDA traces of enzymatic reaction.
IS = internal standard, SM = Starting Material 3.11.
Figure 3.27: The reaction of S1 and AfoD Y118F. PDA traces of enzymatic reaction. IS =
internal standard, SM = Starting Material 3.11, and PRD = Product 3.13.
Figure 3.28: The reaction of S1 and AfoD F237Y. PDA traces of enzymatic reaction. IS =
internal standard, SM = Starting Material 3.11, and PRD = Product 3.13.
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IV. Determination of Enantiomeric Excess
General procedure for in vitro preparative-scale reactions:
Preparative–scale enzymatic reactions were conducted on 5 mg of substrate 3.11 under
the following conditions: 20 `M avin-dependent monooxygenase, 2.5 mM substrate, 1
mM NADP+, 1 U/mL G6PDH, and 5 mM G6P for NADPH generation in reaction buer
(50 mM potassium phosphate buer, pH 8.0). The reaction mixture was added to a 50 mL
Erlenmeyer ask and incubated at 30 ◦C with 100 rpm shaking. After 18 h, the reaction
mixture was diluted with acetone (2 x total reaction volume). Precipitated biomolecules
were pelleted by centrifugation (4,000 x g, 12 min). Isolation procedure: The supernatant
was concentrated under reduced pressure to a nal volume of approximately 1 mL. The
resulting mixture was ltered through a 0.22 `m lter and puried by preparative HPLC
using a Phenomenex Kinetex 5 `m C18, 150 x 21.2 mm column under the following con-
ditions: mobile phase A = deionized water + 0.1% formic acid and B = acetonitrile + 0.1%
formic acid; method = 5% to 100% B over 13 min, 100% B for 4 min; ow rate, 15 mL/min.
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Determination of Enantiomeric Excess
Figure 3.29: PDA traces of racemic 3.13 obtained from an IBX-mediated oxidative
dearomatization, 3.13 obtained from AfoD-mediated oxidative dearomatization CHIRAL-
PAK® ADH, 30%, CO2, 3.5 mL/min.
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Figure 3.30: PDA traces of AfoD Y118F and AfoD F237Y mediated oxidative dearomati-
zation to yield 3.13
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Biochemical Characterization of AfoD wild-type and Variants
pH Prole of AfoD wild-type
Substrate consumption of AfoD wild-type and variants was monitored across a range
of pHs. The pH at which AfoD was optimally active was pH 8.0. Each reaction contained
20 `M enzyme, 50 mM of potassium phosphate buer pH 8.0 (25 `L, 100 mM stock), 2.5
mM substrate (2.5 `L, 50 mM stock), 1 mM NADP+ (0.5 `L, 100 mM stock), 1 mM G6P-DH
(0.5 `L, 100 ` !−1 ), 5 mM G6P (5 `L, 5 mM stock), and Milli-Q water to a nal volume
of 50 `L. Reactions were carried out at 30 ◦C for 2 h and quenched with the addition of
70 `L acetonitrile (HPLC grade) containing 2.5 mM pentamethylbenzene as an internal
standard. Reactions were cleared by centrifugation at 16,000 x g, 12 min and the super-
natant was analyzed by UPLC-DAD. Consumption of the starting material was quantied
by comparison to standard curves of each substrate.
Figure 3.31: The relative eect of pH on AfoD activity with 3.11. Measurements were
done in triplicate Note: Above pH 9.7 protein precipitates cannot determine product for-
mation above that.
111
Reduction of AfoD WT by NADPH
All spectral measurements were carried out on a UV2501PC spectrophotometer (Shi-
mazu). Addition of NADPH was done at 25 ◦C. Reaction conditions: 50 mM phosphate
buer pH 8.0, 800 nM enzyme, 250 `M NADPH, and 125 `M substrate 3.11 was carried
out in a 1 cm pathlength cuvette. Depletion of NADPH was measured at 362 nm.
Hydrogen Peroxide Formation Assay:
Production of hydrogen peroxide was detected by horseradish peroxidase horseradish per-
oxidase (HRP) (2.5 `M) and 4-amino antipyrine (0.75 mM)/2,4,6-tribromo-3-hydroxybenzoic
acid dye (0.02% W/V), phosphate buer pH 8.0 (100 mM). In a 96-well plate, 190 `L of the
assay solution was combined with 10 `L of peroxide (16 `M-3 mM) to generate a peroxide
calibration curve. For reactions, 10 `L of a quenched in vitro reaction was added to 190
`L assay solution to measure peroxide production measured at 510 nm.
Figure 3.32: Peroxide Formation quantication across dierent time points from 30 min
to 120 min after in vitro reaction with substrate 3.11 with AfoD wild-type and variants.
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IV. Sequence Similarity Network (SSN)
Figure 3.33: SSN of avin-dependent monooxygenases created using web tools orig-
inating from the Enzyme Function Initiative (EFI).This SSN encompasses 45,000 non-
redundant FAD-dependent enzyme sequences clustered by sequence similarity. Edge score
between 150 and 1,440 inclusive.
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Figure 3.34: SSN of avin-dependent monooxygenases created using web tools originat-
ing from the Enzyme Function Initiative (EFI). Zoom in to cluster containing TropB, AzaH,
AfoD, and SorbC with and organic layout applied to rearrange the sequences. Edge score
150.
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VI. FDMO Sequence Alignment
Figure 3.35: AfoD cluster sequence alignment with other sequences within its cluster
Y118 and F237 are highlighted. Alignment is colored by conservation.
Figure 3.36: FDMO5 cluster sequence alignment with other sequences within its cluster
Y118 and F237 are highlighted (From AfoD). Alignment is colored by conservation.
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Figure 3.37: TropB cluster sequence alignment with other sequences within its cluster
Y118 and F237 are highlighted (From AfoD). Alignment is colored by conservation.
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CHAPTER IV
Conclusions and Future Directions
There has been an uprising need to access molecules with complex structures and a
desire for chemical reactions that are operationally simple, robust, and environmentally
friendly. In the eld of biocatalysis, we aim to leverage microorganisms and enzymes to
catalyze challenging chemical transformations that meet these requirements for multiple
chemical transformations. [118, 119] However, there has been a gap between identifying
suitable biocatalysts and integrating them in synthetic chemists’ toolbox. [9,120,121] The
body of work in this thesis seeks to identify and characterize new biocatalysts for the syn-
thesis of complex natural products to bridge the gap between discovery and implemen-
tation. We narrowed our scope for the identication of biocatalysts to FAD-dependent
monooxygenases (FDMO), which only require molecular oxygen and a nicotinamide co-
factor for the oxidative dearomatization reaction. Oxidative dearomatization is a pow-
erful chemical transformation that builds complexity in phenolic compounds. FMDOs
can enable this reaction under mild reaction conditions and high site- and stereoselectiv-
ity. [13,22] This Chapter summarizes the results of the preceding two chapters describing
the site- and enantioselectivity of a selection of FMDOs through structural, sequence, and
modeling insights.
We anticipated that FMDOs can provide an excellent platform due to their excep-
tional selectivity. We previously explored the substrate scope and scalability of a panel
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of FDMOs the mediate the oxidative dearomatization reaction. [22] In this initial study,
we demonstrated that three biocatalysts, TropB, AzaH, and SorbC, had high levels of site-
and enantioselectivity across a panel of substrates. Given the excellent reaction prole of
TropB we wanted to enhance its synthetic utility by expanding its substrate scope and
accessing dierent reaction pathways that are not native to the catalyst. We aimed to
gain a structural and mechanistic understanding of this highly selective FDMO, TropB,
to achieve our goal. I solved the TropB crystal structure and upon close inspection of the
active site, we concluded that it was suciently spacious to accommodate a wide range
of substrates. Structural studies coupled with molecular dynamics simulations and mu-
tagenesis studies show that the residues Arg206 and Tyr239 are involved in a two-point
binding of the substrate. Interactions with these residues allow for excellent selectivity.
These ndings will aid with future protein engineering and reaction development eorts
with TropB and related FDMOs.
We wanted to explore how the mechanistic ndings of TropB are translated to other
FMDOs systems. Using the TropB sequence as a template, we employed a sequence simi-
larity network (SSN). This approach enabled a rapid and logical investigation of proteins
that are likely to demonstrate similar reactivity or selectivity reducing the search space
for screening. Through this approach, we identify the FDMO AfoD located between the
clusters of SorbC and TropB, which have complementary enantioselectivity. AfoD yielded
the C3-hydroxylated product similarly to TropB but with complementary stereoselectiv-
ity. Upon close inspection of the sequence alignment of TropB and AfoD, we identied
that AfoD has complementary residues that in the TropB system were critical for selec-
tivity. Taking this sequence ngerprint into consideration, we designed a focused library
that yielded TropB-like products when an equivalent to Tyr239 was present in the ac-
tive site and AfoD-like products when an equivalent to Tyr118 was present in the active
site. Utilizing these modern tools in bioinformatics allowed us to rapidly identify FDMO




Through the bioinformatic tools we have exploited and structural and sequence in-
sights from the FMDOs we have studied we aim to identify new catalysts with complemen-
tary activity. Leveraging the SSN we have built we can canvas and identify biocatalysts
that are similar to TropB and AfoD, but with a more promiscuous substrate scope. This
will allow for selecting enzymes that are similar in reactivity but with perhaps a dier-
ent substrate scope or selectivity depending on how th enzyme selected is clustered. This
approach can be coupled with machine learning and the design of ancestral sequences
between AfoD and TropB. Enzymes have evolved to react with specic substrates nar-
rowing their scope. However, through machine learning, we can take a protein sequence
and computationally predict what the potential ancestral sequence was. We anticipate
that this approach will yield enzymes with a wide range of site-, stereoselectivity and
substrate scope that can be leveraged in the synthesis of complex natural products.
The dierent approaches presented in this dissertation demonstrate the potential that
FMDOs can have in the synthesis of natural products. However, when designing a library
of large scale enzymes they have to be soluble under similar conditions which was a prob-
lem with some of the enzymes within our planned library and might need to be address
in the future when selecting enzymes. The substrate scope of certain enzymes can also
be challenging to predict and relies to be tested experimentally to determine the enzyme
promiscuity across a panel of substrates.
This work highlights the identication of new biocatalysts, structural insights, and
techniques to better canvas the sequence space for a biocatalyst with the desired activity.
I anticipate that as our understanding of the reactivity of dierent FDMOs grows we can
design biocatalysts that t our needs in the future.
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Going beyond the Class A FAD dependent monooxygenases
Currently, there are more than 216 million annotated protein sequences available in
public databases, a number that doubles every 28 months, and just like the deep-sea oor,
only a minuscule portion of this territory has been explored. Combing through these
databases for a well-suited catalyst for the desired reaction with a specic substrate scope
and enantioselectivity can be challenging. For the most part, these sequences are anno-
tated with putative functions. Proling function across a sequence space can be possible
if a subset sample is characterized against a panel of substrates. This approach will allow
researchers to identify trends in reactivity across a family of enzymes and ultimately iden-
tifying enzymes that are capable of the desired reaction. With the evolution of tools avail-
able for canvassing and identifying sequences with untapped synthetic potential, there
can be a leap into determining the function based on the sequences. Some of these tools
include sequence similarity networks (SSNs) and the variational autoencoder latent space
model (VAE), which allow scientists to hone in on motifs that can potentially be used to
predict enzyme function or pinpoint residues that might be important for a specic en-
zyme function. The example in this thesis showcases the power of enzymes that hide in
plain sight. The sequences are known, but their reactivity will remain a mystery without
dedicated experimental work toward family-wide reactivity proling. These eorts are
guided by tools for visualizing sequence space and have the potential to bring light to the
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